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ABSTRACT 
BACKGROUND: 
Hypocalcemia can be a contributory factor for epilepsy and previous 
studies showed that ethanol decreases plasma calcium. Alcohol-related seizures 
are defined as adult onset seizures that occur in the setting of chronic alcohol 
dependence. Alcohol-related seizures are typically brief, generalized tonic-
clonic seizures that occur 6 to 48 h after the last drink. Alcohol 
overconsumption induces multiple effects on kidney function as well as on 
water, electrolyte and acid base homeostasis. Among the electrolyte 
abnormalities observed in alcoholic patients, Hypocalcemia is a common 
feature. Thus, the basis of this study is to  establish the prevalence of 
Hypocalcemia in the general convulsive population and to ascertain if there was 
a specific group of risk for Hypocalcemia among alcoholics.   
AIM OF THE STUDY: 
To establish the role of hypocalcemia in alcohol related seizures in contrast 
to non alcoholic primary idiopathic seizures. To study the prevalence of 
hypomagnesemia in hypocalcemic patients in both alcohol related seizures and 
primary idiopathic seizures. 
MATERIALS AND METHODS: 
This study was formulated as an analytical case control study. Based on 
previous records and by obtaining past history of any CNS infections, 
cerebrovascular accidents, head injury, structural brain lesions, metabolic 
diseases and illicit drug abuse ,patients with all negative history were screened  
with investigations such as serum electrolytes, random blood sugar ,serum 
amylase, serum bilirubin  and CT- brain . Among these patients, patients who 
had all values within normal limits were taken into study population. 
Among the patients in study population, patients with no history of 
alcohol consumption with all screening blood investigations within normal 
limits and those with EEG and CT Brain findings suggestive of primary seizures 
were grouped into control population. Patients satisfying CAGE criteria with 
screening blood investigations and CT-Brain normal were grouped into case 
population. Then, serum calcium levels, serum albumin levels and serum 
magnesium levels were measured in both cases and controls. Corrected calcium 
will be calculated in case of hypoalbuminemia. Serum calcium levels were 
compared in both cases and controls. The prevalence of hypomagnesemia in 
these patients and their association with hypocalcemia were also assessed 
secondarily. The results were tabulated and their statistical significance were 
calculated using pearson’s chi square tests.      
RESULTS: 
On comparing the case and control group , 65.2 % of the hypocalcemic 
patients were in the case group. Only  34.8 % of the patients were in the control 
group. On applying the chi-square tests, the p value is found to be 0.240. Thus, 
there is no statistically significant difference in the prevalence of hypocalcemia 
among the case and control group. On comparing the prevalence of 
hypomagnesemia among hypocalcemic patients in the case group, the p value is 
found to be 0.03 which is statistically significant, but p value was not significant 
in the control group. 
CONCLUSION: 
A high prevalence of Hypocalcemia among alcohol related seizures 
were identified in this study ,though a statistical significance against primary 
seizures could not be proven. The prevalence of Hypomagnesemia was 
statistically significant in the Hypocalcemic alcoholic patients. Thus, 
hypomagnesemia as a cause of seizures in these patients needs further studies.  
KEY WORDS : 
Alcohol related seizures, hypocalcemia , hypomagnesemia. 
INTRODUCTION 
An epileptic seizure is the result of a temporary physiologic dysfunction 
of the brain caused by a self-limited, abnormal, hypersynchronous electrical 
discharge of cortical neurons. A seizure is a transient epileptic event, a symptom 
of disturbed brain function. Seizures may be self-limited in that they occur only 
during the course of an acute medical or neurologic illness; they do not persist 
after the underlying disorder has resolved. 
Parathyroid hormone and vitamin D are the two primary regulators of 
calcium homeostasis. It is the free ionized calcium fraction and not protein-
bound calcium which is responsible for the excitability of muscle cells and 
neurons. The symptoms of Hypocalcemia depends on two factors 
1. the degree of reduction in serum calcium level and  
2. the acuteness of the fall in serum ionized (free) calcium concentration.  
Acute hypocalcemia causes neurologic symptoms primarily because of 
increased neuromuscular excitability. Symptoms are: 
1. Circumoral paresthesia - .numbness and tingling sensation of the 
circumoral region fingers and toes 
2. Muscle cramps 
3. Carpopedal spasm   
4. Tetany producing flexor spasms in the arms and extensor spasms in the 
legs 
5. Laryngeal stridor 
6. Tremors  
7. Chorea  and 
8. Seizures. 
Seizures may occur either in the presence or absence of tetany. The 
various types of seizures in Hypocalcemia are generalized tonic-clonic, focal 
motor, atypical absence and less frequently akinetic seizures.
1,2,3
  Majority of 
the patients presenting with hypocalcemia in the medical emergency, nearly 
about 20 – 25 % had seizures.4 
Alcohol when consumed distributes throughout the body. It affects almost 
all the systems of the body. It alters nearly every neurochemical process in the 
central nervous system .Alcoholism temporarily mimics many medical 
(eg.diabetes mellitus ) and psychiatric (eg. Depression ) conditions 
Ethanol and its oxidative metabolite acetaldehyde has a direct effect on 
both the developing and mature nervous system. Alcohol contains non nutritive 
calories, hence alcohol abuse is complicated by vitamin deficiencies and 
malnutrition. Alcohol overuse causes epileptic seizures.
5 
Alcohol-related seizures are typically brief. It is usually a generalized 
tonic-clonic seizures that occur within 6 to 48 hours after the last drink. Without 
treatment , approximately 60% of patients develop multiple seizures. The 
interval between the first and the last seizure is typically less than 6 hours. 
Alcohol related seizures usually occurs  in the absence of other signs of alcohol  
withdrawal and sympathetic activity such as tachycardia, hypertension and 
fever.
6 
Alcohol abuse causes multiple effects on renal function as well as on 
water, electrolyte and acid base homeostasis. Hypocalcemia is a common 
electrolyte abnormalities observed in alcoholic patients and may be evoked by 
various pathophysiologic mechanisms . 
DEMOGRAPHY 
Epilepsy , a chronic neurological disease is one of the oldest known 
disease to mankind. Epilepsy is the most common neurological disorder 
affecting people of all ages. It is estimated that at any given time about 50 
million people are diagnosed to have epilepsy , with about 80% of these 
individuals residing in developing countries. Seizures accounts for about 1 % of 
the global burden of diseases.
7,8
  In these countries, although most cases can be 
treated, around 75% of people with epilepsy are not receiving appropriate 
treatment.
9 
There is a disparity in the incidence and prevalence of the disease 
across the world. Increased prevalence and incidence can be attributed to factors 
such as low socioeconomic status, infections such as neurocysticercosis and 
access to health care. 
In the integrated disease surveillance project (IDSP) , non-communicable 
disease risk factors survey conducted by Ministry of Health & Family Welfare 
in seven states namely Tamil Nadu, Andhra Pradesh, Kerala, Madhya Pradesh, 
Maharashtra, Mizoram and Uttarakhand  in the year 2007-08
10
 , the 
consumption of alcohol was about 15% of the surveyed population in past 12 
months and 11%  in last 30 days preceding the survey. Among the males about 
6 % were past drinkers. Among the surveyed population , the habit of alcohol 
consumption was higher among men with 30%  in past 12 months as compared 
to only 0.1% among women. The average number of drinks consumed was two 
drinks on a drinking day. Binge drinking (high drinking ) was seen in less than 
five percent of current drinkers. This statistics signifies the burden of 
alcoholism and the health related problems due to alcoholism in our country. 
 
 
 
 
 
 
 
 
AIM OF THE STUDY: 
 
 To establish the role of hypocalcemia in alcohol related seizures in 
contrast to non alcoholic primary idiopathic seizures.  
 To study the prevalence of hypomagnesemia in hypocalcemic patients in 
both alcohol related seizures and primary idiopathic seizures. 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
SEIZURES 
A seizure (from the Latin sacire, "to take possession of") is a paroxysmal 
event due to abnormal excessive or synchronous neuronal activity in the brain.  
The incidence of epilepsy  in different populations throughout the world 
is 0.3 – 0.5 %, and the prevalence of epilepsy has been estimated to be 5–10 
persons per 1000. 
CLASSIFICATION OF SEIZURES 
 
Fig 1: Classification of seizures 
Focal seizures are those which originate within networks limited to one 
cerebral hemisphere . Generalized seizures arise within the cerebral hemisphere 
SEIZURES 
FOCAL GENERALIZED 
ABSENCE 
TONIC 
CLONIC 
TONIC CLONIC ATONIC MYOCLONIC 
UNCLEAR 
and rapidly engage networks distributed across both hemispheres. Structural 
abnormalities of the brain are usually associated with focal seizures whereas 
generalized seizures may result from cellular, biochemical or structural 
abnormalities that may have a more widespread distribution. 
ALCOHOL RELATED SEIZURES 
Alcohol related seizures may be either due to alcohol intoxication or 
alcohol withdrawal. After a period of heavy alcohol consumption , one or more 
generalized tonic-clonic seizures may occur within 48 hours of cessation of 
alcohol consumption. Such patients should be hospitalized for observation for 
atleast 24 hours  to follow the severity of withdrawal symptoms. If the seizures 
is consistently of focal type, the possibility of an associated structural 
abnormality which is often traumatic in origin, must be ruled out. In patients 
with new onset of generalized seizures and whenever there are focal features 
associated with seizures Head CT scan or MRI should be performed . 
Anticonvulsant drugs is generally not required for alcohol withdrawal seizures 
as they are mostly self-limited. Benzodiazepines are the drug of choice and safe 
for preventing further seizures. Status epilepticus may rarely occur following 
alcohol withdrawal . Further attacks are not imminent if the patient abstains 
from alcohol.  
 
ALCOHOLISM 
Alcohol when consumed distributes throughout the body. It affects almost 
all organs in the body. It affects the brain by altering nearly every 
neurochemical process. Ethanol is likely to exacerbate most of the medical 
conditions. It affects almost any drugs metabolized in the liver. It temporarily 
mimics many medical diseases (e.g., diabetes) and psychiatric (e.g., depression) 
illnesses. Almost 80% of people in Western world have consumed alcohol in 
their lifetime , and two-thirds have been drunk in the last year, almost 20% for 
men and 10% for women have the lifetime risk for repetitive  serious alcohol 
related problems , regardless of a person's education status or income. Though 
low doses of alcohol have some health benefits, consumption of more than three 
standard drinks per day on a regular basis increases the risk for cancer, 
cardiovascular and cerebrovascular disease. Alcohol related disorders decrease 
the life span of an individual by about 10 years. 
Alcohol abuse is defined as repetitive problems with alcohol in any one 
of four  areas of life—social, interpersonal, legal, and occupational—or 
repeated use in hazardous situations such as driving while intoxicated in an 
individual who is not alcohol dependent. About 50% of those with alcohol 
abuse continue to have alcohol problems 2–5 years later, but only 10% of these 
patients including adolescents go on to develop alcohol dependence. 
 
ICD-10 DIAGNOSTIC CRITERIA FOR ALCOHOL DEPENDENCE 
EUROPEAN VERSION 
A definite diagnosis of alcohol dependence should usually be made only 
if three or more of the following have been experienced or exhibited at some 
time during the previous year: 
a. A strong desire or sense of compulsion to take alcohol; 
b. Difficulties in controlling alcohol-taking behaviour in terms of its onset, 
termination, or levels of use; 
c. A physiological withdrawal state when alcohol use has ceased or been 
reduced, as evidenced by: the characteristic withdrawal syndrome for alcohol; 
or use of the alcohol with the intention of relieving or avoiding withdrawal 
symptoms; 
d. Evidence of tolerance, such that increased doses of alcohol are required in 
order to achieve effects originally produced by lower doses (clear examples of 
this are found in alcohol-dependent individuals who may take daily doses 
sufficient to incapacitate or kill nontolerant users); 
e. Progressive neglect of alternative pleasures or interests because of alcohol 
use, increased amount of time necessary to obtain or take alcohol or to recover 
from its effects; 
f. Persisting with alcohol use despite clear evidence of overtly harmful 
consequences, such as harm to the liver through excessive drinking; efforts 
should be made to determine that the user was actually, or could be expected to 
be, aware of the nature and extent of the harm. 
PHARMACOLOGY AND NUTRITIONAL IMPACT OF ETHANOL 
Ethanol level in blood is expressed as grams per decilitre. One typical 
drink results in 0.02 gm/dl of blood alcohol level. 
340 ml   beer  
                      10-15 gms of ethanol 
                      (one standard drink) 
115 ml   nonfortified wine 
43 ml     whisky 
               Gin 
               Vodka  
                       Table 1 :Alcohol content in various beverages. 
The alcoholic beverages have additional components called congeners. 
These include methanol, butanol, acetaldehyde, histamine, iron, lead, and 
tannins. They affect the taste and also contributes to the adverse effects of 
alcohol on the body. Alcohol acutely decreases neuronal activity,  
METABOLISM OF ALCOHOL 
Alcohol is absorbed at various levels of the gastrointestinal tract. Small 
amount from mouth and esophagus, modest amount from stomach and large 
bowel and the major site is proximal portion of the small intestine. Rapid gastric 
emptying and absence of proteins , fats or carbohydrates which interferes with 
absorption all increases the rate of absorption. 
Between 2% and 10 % blood alcohol concentration , ethanol is excreted 
through lung , urine or sweat. Ethanol is primarily metabolised in the liver. The 
major pathway occurs in the cell cytosol where ethanol is converted to 
acetaldehyde by alcohol dehydrogenase (ADH), which is then rapidly 
metabolised in cytosol and mitochondria by aldehyde dehydrogenase (ALDH). 
A second pathway called microsomal ethanol – oxidizing system occurs in the 
microsomes of smooth endoplasmic reticulum which metabolises >10 % of 
ethanol at high blood alcohol concentration. 
Alcohol supplies empty calories , that is calories devoid of nutrients such 
as proteins, minerals and vitamins. Alcohol also interferes with absorption of 
micronutrients in the small intestine and reduces the storage in the liver with 
modest effect on thiamine (B1), pyridoxine (B6), folate and vitamin A. 
Chronic alcohol abuse causes thiamine deficiency which accelerates the 
metabolism of ethanol and increases the synthesis of acetaldehyde. Inturn, 
acetaldehyde induces the transketolase activity by acetylation, which is a 
thiamine dependant enzyme . Certain genetic factors also play an important role 
in affecting the transketolase enzyme which makes certain alcoholics more 
susceptible to development of neurological complications. 
EFFECT OF ALCOHOL ON BLOOD SUGAR 
A heavy ethanol load in a healthy fasting individual produces transient 
hypoglycaemia within 6 – 36 hours due to acute actions of ethanol on 
gluconeogenesis. To measure actual blood glucose levels in alcoholics, patients 
has to be abstained from alcohol for 2-4 weeks. The effect of alcohol on 
gluconeogenesis results in temporary abnormal glucose tolerance tests resulting 
in erroneous diagnosis of diabetes mellitus. Alcoholism causes recurrent 
vomiting, poor diet and decrease in fatty acid oxidation  resulting in alcohol 
ketoacidosis which can be misdiagnosed as diabetic ketoacidosis. In alcoholic 
ketoacidosis patients have increase in serum ketones with mild increase in 
serum glucose levels with a large anion gap. There is mild to moderate increase 
in serum lactate and a beta-hydroxybuterate / lactate  ratio of  2:1 to 9:1 (normal 
is 1:1). 
ACUTE ALCOHOL INTOXICATION 
DSM-IV CRITERIA FOR ALCOHOL INTOXICATION 
A. Recent ingestion of alcohol. 
B. Clinically significant maladaptive behavioural or psychological changes 
(e.g., inappropriate sexual or aggressive behaviour, mood lability, impaired 
judgment, impaired social or occupational functioning) that developed during, 
or shortly after alcohol ingestion. 
C. One (or more) of the following signs, developing during, or shortly after, 
alcohol use: 
1. Slurred speech 
2. Incoordination 
3. Unsteady gait 
4. Nystagmus 
5. Impairment in attention or memory 
6. Stupor or coma 
D. The symptoms are not due to a general medical condition and are not better 
accounted for by another mental disorder. 
Mild 0.5 – 1.5 % 
Moderate 1.5 – 2.5 % 
Severe >2.5 % 
                           Table 2 : Severity and blood alcohol  level  
Mild 1.impaired concentration , behaviour and self control 
2.decreased psychomotor activity 
3.black-outs 
4.minimal cerebellar symptoms – nystagmus 
5.extreme excitement, violence and psychotic 
reaction 
6.hangover symptoms- nausea, vertigo,malaise, 
headache, tremors, lack of concentration 
Moderate  1.psychosocially uncontrolled 
2.aggressive on exogenous stimuli 
3.euphoria, dysphoria or depression 
4. nystagmus, slurred speech, ataxia, vertigo 
5. nausea, tachycardia, sweating 
Severe 1.disorientation, somnolescence and coma 
2.marked cerebellar and autonomic symptoms 
3.fatal respiratory paralysis 
Table 4: Severity and symptoms of alcohol intoxication 
DISORDERS OF CNS 
ALCOHOL INDUCED SEIZURES 
Seizures are the most common neurological effect of chronic alcohol 
abuse regardless of the duration of abuse.
11,12
 The prevalence rate is about 20- 
35 %. Both alcohol intoxication as well as alcohol withdrawal can cause 
seizures. Usually cessation of alcohol for about one to two days can lead to 
generalised tonic clonic seizures or focal seizures. The pathophysiological 
mechanisms causing seizures in alcoholics remains unknown, but dysregulation 
of potassium, magnesium , calcium and  neurotransmitters such as glutamate 
and GABA are being proposed. 
Clinical examination reveals no neurological deficits. EEG is normal. 
Minor EEG slowing and decreased alpha activity may be seen in some patients. 
EEG and CT scan-brain diagnosis is required to exclude focal brain injury in 
new onset epileptic seizures. Status epilepticus  may occur in about 2 to 10% of 
the patients. About 30% of the patients with withdrawal seizures may progress 
to delirium tremens.
13 
Focal seizures are suggestive of focal brain injury such as head injury, 
haemorrhage, encephalopathy, malignancy and metabolic disorders such as 
hypoglycemia  and  electrolyte disturbances. Clinical examination shows focal 
neurological signs, such as motor, sensory or cranial nerve dysfunction. 
Therefore, laboratory investigations, CT scan and EEG should be performed. 
EEG may show paroxysmal or non-paroxysmal, focal or diffuse  abnormalities. 
Depending on detected focal brain injury, further investigations or procedures 
may be considered. In general, these patients require hospital admission. 
In addition, seizures due to pre-existing genuine epilepsy may be 
provoked or unmasked by alcohol abuse. EEG may show focal spiking. The 
first appearance of an seizure requires a detailed examination and 
investigations, but usually no acute treatment for the seizure is necessary . If 
patient has symptomatic epilepsy or develops  status epilepticus , treatment is 
necessary. If the history is unreliable, antiepileptic drugs can be given for a 
short duration, but long-term treatment is usually not indicated for alcohol-
induced seizures because of usually coexisting alcoholic liver disease and poor 
compliance. Prophylactic anticonvulsant therapy are recommended in alcoholics 
with known withdrawal seizures during detoxification. 
CEREBROVASCULAR DISEASES 
 Chronic alcohol abuse has an increase in the risk of intracerebral and 
subarachnoid haemorrhages. It lowers the prognosis of bleeding from 
intracerebral aneurysms and also increases the relapse rate.
14 
The factors 
responsible for higher incidence of acute intracerebral haemorrhage and chronic 
subdural hematoma are head injury , seizures and concomitant liver disease due 
to alcohol abuse. Chronic alcohol abusers are more prone for ischemic disorders 
due to elevated blood pressure, changes in renin, aldosterone, cortisol and 
vasopressin levels and due to alteration in adrenergic transmitter system.
15 
Arterial hypertonia and cerebral vasospasm
 
due to sympathetic activation may 
occur in alcohol intoxication as well as alcohol withdrawal.
16 
Excess smoking 
habit among alcoholics increase the risk of atherosclerosis. However , 
cerebrovascular and cardiovascular protective effect has been demonstrated 
when alcohol is taken in small amounts on a regular basis.
17 
 
CEREBELLAR DEGENERATION 
 Cerebellar atrophy may develop in about 30% of patients with chronic 
alcohol intake beyond fourth decade. Patients may progressively develop stance 
and gait ataxia , tremors , nystagmus and dysarthria. On alcohol abstinence , 
thiamine therapy and physiotherapy initial stages may be reversible. 
DEMENTIA AND ENCEPHALOPATHY 
 Cognitive impairment is seen in about 75% of chronic alcohol abusers.
18 
Wernicke’s encephalopathy is characterised by triad of global confusion , ataxia 
and ophthalmoplegia.
19
 Only about 10 % of the patients exhibit all the three 
features. Korsakoff’s psychosis is characterised by memory impairment, 
confabulation, confusion and personality changes . In about 80 % of the patients 
MRI shows atrophy of mammillary bodies.
20
 In acute phase the mortality of 
Wernicke’s encephalopathy varies between 10 to 20 % due to midbrain 
haemorrhage.
21
 Another important cause of encephalopathy in these patients are 
due to hepatic damage. 
ALCOHOL WITHDRAWAL SYNDROME 
 A state in patients consuming alcohol for prolonged periods ,who 
suddenly stops the  intake or reduces the amount of alcohol is referred to as 
Alcohol withdrawal syndrome (AWS). About 50% of alcohol dependent 
patients shows the symptoms and signs of AWS after stoping or reducing the 
amount of alcohol  depending on the total duration of alcohol consumption and 
quantity of alcohol consumed.
22
 The correct dose of alcohol causing physical 
dependence is unclear and widely varies. Patients with moderate to severe AWS 
consumes approximately 300 g of alcohol per day.
23.24 
It takes atleast 6 years for 
the appearance of first withdrawal symptom on cessation of alcohol ,from the 
onset of alcohol abuse.
25 
DSM-IV CRITERIA FOR ALCOHOL WITHDRAWAL 
A. Cessation of (or reduction in) alcohol use that has been heavy and prolonged. 
B. Two (or more) of the following, developing within several hours to a few 
days after 
criterion A: 
1. Autonomic hyperactivity (e.g., sweating or pulse rate greater than 100) 
2. Increased hand tremor 
3. Insomnia 
4. Nausea or vomiting 
5. Transient visual, tactile, or auditory hallucinations or illusions 
6. Psychomotor agitation 
7. Anxiety 
8. Grand-mal seizures 
C. The symptoms in criterion B cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
D. The symptoms are not due to a general medical condition and are not better 
accounted for by another mental disorder. 
Symptoms of AWS 
 Tremors 
 Nausea / vomiting  
 
 Increased sweating 
 
 Tachycardia 
 
 Lack of sleep 
 
 Headache 
 
 Fever 
 
 anxiety 
 
 Psychomotor agitation 
 
 Lack of orientation 
 
 Attention deficit 
 
 Hallucinations 
 
  Seizures  
Abnormal Laboratory Parameters in AWS 
 Increase in liver enzymes (AST, ALT, GGT) 
 Increased  alkaline phosphatase 
 Reduced platelet count 
 Dimorphic  anemia (MCV, MCH) 
 Increase in serum ammonia and bilirubin 
 Electrolyte abnormalities (hypokalemia, hypocalcemia, hypomagnesemia, 
hyponatremia) 
TREATMENT OF AWS 
Clinical Institute Withdrawal Assessment Scale for Alcohol, revised 
(CIWA-Ar ) is an objective criteria for assessment of the severity of AWS and 
is also used as a guide for the treatment of AWS.
26
 The scale can be applied 
hourly or on a daily basis in patients suffering from AWS and is helpful in 
dosing the medications according to the severity. 
The following factors determines the decision to treat AWS  as an 
inpatient or outpatient , with or without a pharmacological agent  
1. The duration of alcohol abuse, 
2. Presence of concomitant diseases, and  
3. Previous history of AWS.27   
Factors responsible for the development of severe withdrawal syndrome 
are seen in patients with 
 History of  alcohol abuse for more than 6 years,  
 Elderly,  
 History of seizures, 
 Delirium 
 History of detoxifications . 
Benzodiazepines are the first drug of choice in the treatment of AWS.
28
 
They are the most effective drug in treating withdrawal symptoms such as 
tremors, anxiety, insomnia, for prevention of seizures and in reducing the risk of 
developing delirium tremens.
29
 Diazepam are most efficient against withdrawal 
seizures than lorazepam or oxazepam.
30
 . Intravenous benzodiazepines are better 
choice in severe withdrawal symptoms and delirium.
31
 The various parenteral 
formulations available are diazepam, chlordiazepoxide, midazolam and 
lorazepam. 
Among the anticonvulsants, carbamazepine has been proved to be very 
helpful in AWS. However , it is not helpful in case of delirium tremens. It is 
also useful in preventing seizures and has no cross-tolerance with ethanol .
32 
As an add on therapy to benzodiazepines, antipsychotics (e.g., 
haloperidol) can be used in  case of delirium. Hallucinations can be treated with 
haloperidol successfully. Sympatholytics for symptomatic improvement. 
MECHANISM OF HYPOCALCEMIA IN ALCOHOLICS 
Alcohol abuse leads to multiple effects on kidney functions including 
water, electrolyte and acidbase balance.
33-35
 Among the electrolyte 
abnormalities noted in alcoholic patients, hypocalcemia is a common finding 
and may be as a result of various pathophysiologic mechanisms, which are not 
yet well understood. 
 
i. Magnesium depletion could lead to decreased calcium levels largely due 
to impaired release of parathormore (PTH) and also due to skeletal 
resistance to the action of PTH .
36
 
ii. The tubular reabsorption of calcium in kidneys is reduced due to the 
effect of ethanol in decreasing the Na+,K+-ATPase activity in the 
proximal tubular cells .
37
 
iii. The suppressed secretion of PTH resulting from acute alcohol 
consumption
38
 or hypomagnesemia could further contribute to the 
decreased tubular reabsorption of calcium. 
iv. Renal PTH resistance is induced by severe respiratory alkalosis  resulting 
in hyperphosphatemia, calciuria and hypocalcemia.
39
 
v. chronic pancreatitis in alcoholics can cause vitamin D3 deficiency due to 
its decreased intestinal absorption .
40
 
 
DIAGNOSIS OF ALCOHOL RELATED SEIZURES 
HISTORY TAKING 
 A detailed drinking history that indicates alcohol overuse should be 
obtained to make a clinical diagnosis of alcohol related seizures. Frequently the 
true levels of alcohol consumption are under reported. A detailed history of 
recent alcohol intake should be asked whenever possible. History of alcohol 
withdrawal symptoms should be obtained. 
 A detailed drinking history should include both the frequency and 
quantity of alcohol intake during the past 5 days, any changes in drinking 
pattern as well as the time of last alcohol intake should be asked. 
 Many legal or illegal pharmacological agents have the tendency to cause 
seizure due to their direct neurotoxic effect (eg: antidepressants, antipsychotics) 
or either due to withdrawal (eg:benzodiazepines). Thus, history of any other 
drug abuse should be asked for as they can complicate the clinical picture. 
 
 
QUESTIONNAIRES 
 Alcohol overuse and dependence as well as excessive alcohol 
consumption can be graded and revealed by using structured questionnaires. 
Questionnaires should be brief and reliable. The most commonly used four 
simple question questionnaire is the CAGE criteria.
41
 It is easy to remember and 
has a fair accuracy. Sensitivity and specificity data for the CAGE range from 73 
to 97% and 72 to 96%, respectively . But, the drawback of this questionnaire is 
that it fails to recognise binge drinking. This can be assessed by asking the 
history of taking largest number of drinks in one single occasion. 
CAGE QUESTIONNAIRE: 
Cut down     1. Have you ever felt that you ought to 
cut down on your drinking? 
Annoyed 2. Have people annoyed you by 
criticizing your drinking? 
Guilty     3. Have you ever felt bad or guilty 
about your drinking? 
Eye opener   4. Have you ever had a drink first 
thing in the morning to steady          
your nerves or get rid of a hangover? 
Table 4 : CAGE criteria 
Another commonly used questionnaire model is published in 1989 by the 
World Health Organization 
42.43 
the Alcohol Use Disorder Identification Test 
(AUDIT)  consists of ten questions assessing frequency and quantity of alcohol 
use, dependence symptoms, personal and social harm attributed to excessive 
alcohol use. This is a 10 item model which takes about 2-3 minutes to interview. 
It is graded from 0 -40. Responses to individual questions are given a score 
varying from 0 to 4, with a test score of 8 or higher indicating the presence of 
hazardous drinking.  For patients consuming lower drinking levels, AUDIT has 
a better accuracy than CAGE criteria . the major disadvantage is it is difficult to 
remember and consumes more time to interview amidst busy medical settings. 
AUDIT 
1.How often do you have a drink 
containing alcohol? 
(0) Never 
(1) Monthly or less 
(2) Two to four times a month 
(3) Two to three times a week 
(4) Four or more times a week 
2. How many drinks containing 
alcohol do you have on a typical day 
when you are drinking? 
(0) 1 or 2 
(1) 3 or 4 
(2) 5 or 6 
(3) 7 to 9 
(4) 10 or more 
3. How often do you have six or more 
drinks on one occasion? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
4. How often during the last year have 
you found that you were not able to 
stop drinking once you had started? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
5.How often during the last year have 
you failed to do what was normally 
expected from you because of 
drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
6. How often during the last year have 
you needed a first drink in the morning 
to get yourself going after a heavy 
drinking session? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
7. How often during the last year have (0) Never 
you had a feeling of guilt or remorse 
after drinking? 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
8. How often during the last year have 
you been unable to remember what 
happened the night before because you 
had been drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
9. Have you or someone else been 
injured as a result of your drinking? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
10. Has a relative or a friend, or a 
doctor or other health worker, been 
concerned about your drinking or 
suggested you cut down? 
(1) Now 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
Table 5: AUDIT criteria 
Other questionnaires available widely are MICHIGAN ALCOHOLISM 
SCREENING TEST (MAST) and Munich Alcoholism Test (MALT).  If time 
consumption is of a concern, two abbreviated versions of the MAST, the ten-
question Brief MAST (BMAST) and the thirteen question Short 
MAST(SMAST), have been developed and can be widely used as a suitable 
alternative measures. 
BIOCHEMICAL PARAMETERS USED FOR DIAGNOSIS OF 
ALCOHOLISM 
•Alcohol levels in 
          breath, blood, urine 
•Blood constituents 
  Total Proteins 
  Albumin 
           Globulins (gamma and alpha) 
           Carbohydrate-deficient transferrin (CDT) 
•Complete blood count 
  Erythrocyte  count 
  Leukocyte count 
  Packed cell volume 
  Mean corpuscular hemoglobin (MCH) 
  Mean corpuscular volume (MCV) 
•Blood lipids 
  Total Cholesterol 
  Triglycerides 
  HDL and LDL- cholesterol 
•Liver function tests 
  Aspartate aminotransferase (AST) 
  Alanine aminotransferase (ALT) 
  AST:ALT ratio 
  Alkaline phosphatase(ALP) 
  gamma-glutamyl transferase (GGT) 
  GGT:ALP ratio 
  Glutamate dehydrogenase 
Though questionnaire-based interview model is more sensitive than using 
biomarkers for detecting alcohol overuse , these biomarkers can be used when 
information on alcohol consumption is not reliable or unavailable.
44-47 
The most recently identified  biochemical marker for alcohol abuse has 
been found out to be carbohydrate-deficient transferrin. Normal human 
transferrin contains three or more sialic acid residues. In individuals with 
excessive alcohol abuse there is an  elevated concentrations of transferrin 
isoforms with a decreased content of sialic acids and other carbohydrate 
residues.
48 
The two sensitive markers for alcohol overuse is carbohydrate deficient 
transferrin (CDT) and gamma glutamyl transferase (GGT). Both the biomarkers 
have poor accuracy in screening alcohol related seizures.
49
 A combination of 
both tests have increased sensitivity.
50-52
 As the level of intoxication is very 
important in any alcohol related seizures , blood alcohol levels should be 
measured whenever possible.
53
  
PATIENT EXAMINATION AND OBSERVATION 
 The clinical institute withdrawal assessment scale (CIWA-Ar) 
questionnaire model can be used to grade the severity of alcohol withdrawal 
symptoms.
54
 This can be used as a supportive tool to make decision regarding 
whether to keep or discharge the patient. This model takes about 2-5 minutes to 
administer. The grading of severity varies from 0-67 . 
 Nearly 90% of the alcohol withdrawal seizures occur in the first 48 hours 
of stopping prolonged drinking. The patient should be observed for atleast 24 
hours as inpatient. A clinical assessment should be made later depending on the 
development of symptoms of alcohol withdrawal. 
 The symptoms and signs used to differentiate the post-ictal state of 
primary seizures and the early alcohol withdrawal syndrome are as follows. In a 
patient with primary seizure , the patient will have post ictal sleep or drowsiness 
with a calm mood whereas patients in alcohol withdrawal will be sleepless with 
an anxious mood. Tremors and sweating are usually absent in primary seizures 
whereas it is a predominant feature in alcohol withdrawal. On examination the 
pulse rate and blood pressure will be normal in primary seizures whereas 
alcohol withdrawal can have tachycardia and increased blood pressure.  Alcohol 
withdrawal can have increased temperature and their arterial blood analysis may 
show respiratory alkalosis. 
NEUROIMAGING 
 Any patient presenting with first episode of alcohol related seizures 
should have their cerebral computed tomography (CT) done , as the incidence 
of structural intracranial lesions is very high in alcohol overusing patients.
55,56
 
Etiologies other than simple alcohol withdrawal such as brain contusion, 
subdural hematoma, combined drug and alcohol overuse are possible causes for 
seizures later than 48 hours .
57
 Repeat neuroimaging is not necessary in patients 
presenting with repeated typical alcohol related seizures . Repeat neuroimaging 
is necessary in the following situations: 
1. Change in seizure type and frequency 
2. Seizures occurring later than 48 hours after cessation of alcohol 
consumption. 
3. Unusual presentations. 
 
ELECTROENCEPHALOGRAPHY (EEG) 
 The incidence of EEG abnormalities is lower in patients with alcohol 
related seizures when compared with patients with seizures of other etiologies. 
Thus, EEG is done in patients presenting with first episode of alcohol related 
seizures to rule out other possible aetiologies of seizures. Repeat investigation is 
necessary only if alternative aetiology is suspected in patients with repeated 
alcohol withdrawal seizures.  
PATIENT MANAGEMENT 
 The acute management of alcohol related seizures focuses on the 
complications of alcohol abuse and dependence such as 
 Thiamine deficiency 
 Electrolyte disturbance 
 Infections 
 Acute intracranial lesions 
 Presence of alcohol withdrawal syndrome 
THIAMINE THERAPY 
 Excessive alcohol consumption causes thiamine deficiency both by 
reducing absorption and by increasing excretion. The incidence of Wernicke’s 
encephalopathy is about 5-14%. About 80% of patients having CNS pathology 
suggestive of thiamine deficiency are chronic alcohol abusers. Identification of 
patients with thiamine deficiency is very difficult, but the consequences of 
thiamine deficiency undertreated is very severe. Therefore, wherever suspected, 
treatment of thiamine deficiency should be initiated. 
 In chronic alcoholics the intestinal absorption of thiamine is severely 
impaired , hence oral administration of thiamine is insufficient.
58
 In a recent 
Cochrane review , it could be concluded that dose of 200 mg thiamine daily was 
better than 5 mg daily.
59
 Amny trials on imminent and manifest Wernicke’s 
encephalopathy suggest a daily dose of about 200 mg parenteral thiamine for 
about 5 days . Few studies recommend continued treatment for period of 2 
weeks or longer. 
 Thus any patients presenting in the emergency department with 
symptoms of alcohol overuse or alcohol related seizures, should be treated with 
prophylactic thiamine therapy before starting any carbohydrate containing fluids 
or food. 
TREATMENT OF ELECTROLYTE DISTURBANCES 
 Due to large quantity of fluid intake, alcoholic abusers are more prone for 
hyponatremia. Hyponatremia in alcoholics generally have a benign course 
clinically
60
 which  usually gets corrected on alcohol cessation and on restoration 
of normal diet.
61  
If correction is needed , the rate of sodium correction should 
not be more than 10 mmol/day.
62 
 Rapid correction of hyponatremia can lead to 
central pontine myelinolysis.
63 
 Hypomagnesemia and respiratory alkalosis may be present in alcohol 
withdrawal. Hypomagnesemia correction may increase the threshold for 
seizures in the initial phase of ethanol withdrawal.
64
 Hypomagnesemia can 
cause unresponsiveness to parenteral thiamine therapy.
65
 There is no sufficient 
data supporting the routine correction of hypomagnesemia in alcoholics. 
PRIMARY PREVENTION OF ALCOHOL WITHDRAWAL SEIZURES 
When pharmacological treatment is needed, benzodiazepines should be 
drug of choice for the primary prevention of seizures in a person with alcohol 
withdrawal, as well as for treatment of the alcohol withdrawal syndrome. The 
drugs of choice are diazepam and lorazepam. 
SECONDARY PREVENTION 
 Following a withdrawal seizure, the recurrence risk within the same 
withdrawal episode is 13 – 24%.66 For the secondary prevention of AWS, 
benzodiazepines should be used. Lorazepam reduces recurrence risk 
significantly . 
67
Phenytoin will not prevent the relapse of seizures in individuals 
who had several episodes during the same withdrawal episode. 
 
MANAGEMENT OF SEIZURES IN PATIENTS WITH CURRENT 
ALCOHOL OVERUSE 
The management of epilepsy in patients with alcohol abuse includes 
detailed counselling and information about the seizure - precipitating effect of 
ethanol. The concurrent withdrawal of alcohol and anticonvulsant drugs may 
lead to serious effects. Prescription of antiepileptic drugs to alcohol abusers is 
often useless, which may increase the occurrence of seizures due to drug - 
alcohol interactions,  poor compliance and drug overuse.
68
 The anticonvulsant 
drugs prescribed for such patients should be tolerated well when taken with 
ethanol and should have a benign side effect  and should be safe in overdose 
also
69
, and should have a suppressive action on drinking behaviour. In a few 
studies, sodium valproate, carbamazepine , gabapentin, and pregabalin have  
been reported to decrease alcohol consumption 
70-73
 , and topiramate has been 
shown to reduce alcohol craving recently . 
74 
DISTRIBUTION OF CALCIUM AND CALCIUM HOMEOSTASIS 
Most calcium is bound and associated with bone structures (99%). The 
majority of free calcium, either in diffusible non ionized form or in ionized form 
(Ca2+), is found in the intracellular and extracellular fluid compartments. There 
is a steep concentration gradient of Ca2+ between the intracellular and the 
extracellular milieu.  
Fig 2: Distribution of calcium in extracellular and intracellular spaces. 
  
The plasma concentration of Ca2+ is tightly regulated by the actions of 
parathyroid hormone (PTH) and calcitriol (1,25-dihydroxycholecalciferol). The 
physiologic role of other calcium regulatory hormones, such as calcitonin, 
estrogens, and prolactin, is less clear.   
 
calcium 
extracellular 
total:9–10.6 mg/dl 
2.25–2.65 mmol/l 
Protein bound 45% 
Diffusible 
(ultrafilterable) 55% 
Free 
ionized 
45% 
Complexed 
10% 
intracellular 
(cytoplasmic free) 
50–100 nmol/l 
Figures 3 and  4 demonstrate the physiologic defence mechanisms used to 
counter changes in serum Ca2+ levels. Serum Ca2+ levels are also influenced 
by acid-base status; alkalosis causes a decrease in Ca2+, and acidosis has the 
opposite effects.  
 
 
Fig 3 : Defence against hypercalcemia 
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Fig 4: Defence against hypocalcemia 
Long-term maintenance of calcium homeostasis depends on the 
adaptation of intestinal Ca2+ absorption to the needs of the organism, on the 
balance between bone accretion and resorption, and on urinary excretion of 
calcium (fig 5). 
decreased plasma 
ca2+ 
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sensing receptors 
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decreased fractional 
renal ca2+ excretion 
 Increased mobilization of 
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 Fig 5: Calcium homeostasis in the healthy adult. Net zero Ca2+ balance is 
the result of net intestinal absorption (absorption minus secretion) and urinary 
excretion. 
INTESTINAL, SKELETAL, AND RENAL HANDLING OF CALCIUM 
Gastrointestinal calcium absorption is a selective process; only about 
25% of total dietary calcium is absorbed. Ca2+ transport across the intestinal 
wall occurs in two directions: absorption and secretion. Absorption can be 
subdivided into transcellular and paracellular flow .
75
 Transcellular calcium flux 
takes place through the recently identified TRPV6 calcium channel. Calcitriol is 
its most important hormonal regulatory factor.
76
 After binding to and activating 
the vitamin D receptor (VDR), calcitriol increases active transport by inducing 
the expression of TRPV6, calbindin D9k, and Ca2+-ATPase (PMCA1b). Other 
hormones, including estrogens, prolactin, growth hormone, and PTH, also 
stimulate Ca2+ absorption, either directly or indirectly. The amount of dietary 
calcium intake also regulates the proportion of calcium absorbed through the 
gastrointestinal tract.  
 
Fig 6: Transepithelial calcium transport in the small intestine 
Cutaneous synthesis on exposure to UV light converts 7-
dehydrocholesterol to vitamin D substrate (cholecalciferol). Cholecalciferol has 
minimal inherent biologic activity and requires two hydroxylation steps for full 
hormonal activity. 25-Hydroxylation occurs in the liver. Further hydroxylation 
to 1,25-dihydroxyvitamin D (calcitriol) occurs predominantly in the kidney, but 
also occurs in non-renal tissues. 
Increased calcium absorption is required in puberty, pregnancy, and 
lactation. In all these states, calcitriol synthesis is increased. Intestinal Ca2+ 
absorption is also increased in vitamin D excess and acromegaly. Rarely, the 
ingestion of calcium and alkali in large quantities can overwhelm 
gastrointestinal checks on calcium absorption, resulting in hypercalcemia (milk-
alkali syndrome); however, innate limitations on gastrointestinal calcium 
absorption prevent this condition from occurring in most individuals.  
A decrease in intestinal Ca2+ transport occurs in a low Ca2+/phosphate 
ratio in the food, a high vegetable fibre and fat content of the diet, corticosteroid 
treatment, estrogen deficiency, advanced age, gastrectomy, intestinal 
malabsorption syndromes, diabetes mellitus, and renal failure. The decrease in 
Ca2+ absorption in the elderly probably results from multiple factors in addition 
to lower serum calcitriol and intestinal VDR levels.
77
 The net balance between 
Ca2+ entry and exit fluxes is positive during skeletal growth in children, zero in 
young adults, and negative in the elderly. 
 Exchangeable skeletal Ca2+ contributes to maintenance of extracellular 
Ca2+ homeostasis. Several growth factors, hormones, and genetic factors 
participate in the differentiation from the mesenchymal precursor cell to the 
osteoblast and the maturation of the osteoclast from its granulocyte macrophage 
precursor cell . The regulation of bone formation and resorption involves a large 
number of hormones, growth factors, and mechanical factors.
78
  
  The kidneys play a major role in the minute-by-minute regulation; the 
intestine and the skeleton ensure homeostasis in the mid and long term. To 
perform its task, the kidney uses a complex system of filtration and 
reabsorption. The adjustment of blood Ca2+ is mainly achieved by modulation 
of tubular Ca2+ reabsorption in response to the body’s needs, perfectly 
compensating minor increases or decreases in the filtered load of calcium at the  
glomerular level, which is normally about 220 mmol (8800 mg) in 24 hours.  
In the proximal tubule, most of the Ca2+ is reabsorbed by convective 
flow (as for Na+ and water); in the distal segments of the tubule, the transport 
mechanisms are more complex. States of excess volume delivery to the kidney, 
such as a high-sodium diet, diminish the concentration gradient between 
proximal tubule and peritubular capillary, reducing calcium absorption and 
increasing calcium in the urine. This mechanism is thought to play a role in the 
pathogenesis of calcium-based kidney stones. On the other hand, volume 
depletion states increase salt, water, and (by convection) calcium reabsorption 
in the proximal tubule, exacerbating states of hypercalcemia.  
 
 
Fig 7: Sites of calcium reabsorption in various segments of the renal tubule 
 
In the thick ascending loop, the transport of Ca2+ is primarily passive by 
the paracellular route, depending on the electrical gradient, with the tubular 
lumen being positive, and also on the presence of claudin 16 in the tight 
junction. At this step, Ca2+ transport is enhanced by PTH, probably through an 
increase in paracellular permeability, but it is reduced by an increase in 
extracellular Ca2+ involving the Ca2+-sensing receptor (CaRG). Specifically, 
stimulation of CaRG by elevated serum calcium levels decreases the activity of 
rectifying K+ channels (ROMK), resulting in less Na+-K+-2Cl− cotransporter 
activity and less calcium reabsorption in this segment. In the distal tubule, Ca2+ 
transport is primarily active by the transcellular route, through TRPV5 located 
in the apical membrane and coupled with a specific basolateral Ca2+-ATPase 
(PMCA1b) and a Na+-Ca2+ exchanger (NCX1). Both PTH and calcitriol 
regulate distal tubular transport.  
 Numerous factors control the glomerular filtration and tubular 
reabsorption of Ca2+. Elevated renal blood flow and glomerular filtration 
pressure (during extracellular fluid volume expansion) lead to an increase in 
filtered load, as do changes in the ultrafiltration coefficient Kf and an increase 
in glomerular surface. True hypercalcemia also increases ultrafilterable calcium, 
whereas true hypocalcemia decreases it. PTH decreases glomerular Kf and thus 
reduces the ultrafiltered calcium load; it also increases Ca2+ reabsorption in the 
distal nephron. However, PTH and PTH-related peptide (PTHrP) also induce 
hypercalcemia, and because of the increase in serum calcium, the excretion of 
filtered calcium is elevated overall. Both extracellular Ca2+ and intracellular 
Ca2+ reduce tubular calcium reabsorption by activating CaRG, and the effect of 
extracellular Ca2+ is enhanced by calcimimetics.  
Metabolic and respiratory acidosis lead to hypercalciuria, respiratory 
acidosis through an increase in plasma Ca2+ and metabolic acidosis through 
calcium release from bone and an inhibitory effect on tubular Ca2+ 
reabsorption. Conversely, alkali ingestion reduces renal excretion of calcium. 
The enhancing effect of phosphate depletion on urinary calcium elimination can 
partly occur through changes in PTH and calcitriol secretion.  
Dietary factors modify urinary excretion of calcium, mostly by their 
effects on intestinal Ca2+ absorption. Several classes of diuretics act directly on 
the tubules: loop diuretics and mannitol favor hypercalciuria, with a major 
impact on the thick ascending limb, whereas the thiazide diuretics and amiloride 
induce hypocalciuria. 
 
HYPERCALCEMIA 
Increased plasma total calcium concentration can result from an increase 
in plasma proteins (false hypercalcemia) or from an increase in plasma ionized 
Ca2+ (true hypercalcemia). Only the latter leads to clinically relevant 
hypercalcemia.  When only the value for the total plasma calcium concentration 
is available rather than the free level ions, plasma Ca2+ can be estimated by 
taking into account plasma albumin:  an increase in albumin of 1.0 g/dl reflects 
a concomitant increase of 0.20 to 0.25 mmol/l (0.8 to 1.0 mg/dl) in plasma 
calcium 
ETIOLOGIES OF HYPERCALCEMIA 
 Primary hyperparathyroidism 
 Primary adenoma 
 Primary diffuse hyperplasia 
 Primary adenocarcinoma 
 Multiple endocrine neoplasias (MEN-1, MEN-2A) 
 Other endocrinopathies 
 Hyperthyroidism 
 Acromegaly 
 Pheochromocytoma 
 Acute adrenal insufficiency 
 Tertiary hyperparathyroidism 
 Chronic renal failure 
Neoplastic diseases 
               Solid tumors 
 Breast cancer 
 Bronchial cancer 
 Renal cancer 
 Thyroid cancer 
Neoplasias of hematopoietic system 
 Myeloma 
 Lymphoma 
 Leukemia 
Vitamin intoxication 
 Hypervitaminosis D 
 Hypervitaminosis A 
Familial hypocalciuric hypercalcemia 
              Granulomatous diseases 
 Sarcoidosis 
 Tuberculosis  
 Berylliosis 
 Coccidioidomycosis 
 Histoplasmosis 
 Leprosy 
 Silicon-induced granulomas 
Pseudohyperparathyroidism (Jansen's disease) 
              Others 
 Immobilization 
 Treatment with certain medications (thiazides, lithium, 
theophylline) 
 Milk-alkali syndrome 
 Recovery phase of acute renal failure (rhabdomyolysis) 
 False hypercalcemia (by hemoconcentration) 
Clinical Manifestations 
The severity of clinical symptoms and signs caused by hypercalcemia 
depends not only on the degree but also on the velocity of its development. 
Severe hypercalcemia can be accompanied by few manifestations in some 
patients because of its slow, progressive development, whereas much less 
severe hypercalcemia can lead to major disorders if it develops rapidly. 
 First symptoms  
 increasing fatigue, 
 muscle weakness, 
 inability to concentrate, 
 nervousness, 
 increased sleepiness,  
 depression.  
 gastrointestinal signs-  constipation, nausea and vomiting 
 peptic ulcer disease 
 pancreatitis.  
 Renal-related signs include polyuria (secondary to nephrogenic 
diabetes insipidus),  
 urinary tract stones and their complications,  
 tubulointerstitial disease with medullary and to a lesser extent 
cortical deposition of calcium (nephrocalcinosis). 
 Neuropsychiatric manifestations include headache, loss of 
memory, somnolence, stupor, and, rarely, coma. 
 Ocular symptoms include conjunctivitis from crystal deposition 
and, rarely, band keratopathy. 
 Osteoarticular pain  
 High blood pressure  
 Soft tissue calcifications can occur with long-standing 
hypercalcemia.  
 Electrocardiography may show shortening of the QT interval and 
coving of the ST wave. 
 Hypercalcemia may also increase cardiac contractility and can 
amplify digitalis toxicity. 
 
HYPOCALCEMIA 
Symptomatic hypocalcemia is  defined as reduction in the serum ionized 
(free) calcium concentration, or as a serum calcium level less than 8.5 mg/dL in 
the presence of normal levels of serum proteins. The total serum calcium 
concentration is reduced by approximately 0.8 mg/dL for every 1 g/dL 
reduction in serum albumin concentration. Occasionally, symptomatic 
hypocalcemia can occur with normal total serum calcium concentration . 
Like hypercalcemia, hypocalcemia can be secondary either to reduced 
plasma albumin (false hypocalcemia) or to a change in ionized Ca2+ (true 
hypocalcemia). False hypocalcemia can be excluded by direct measurement of 
plasma Ca2+, by determination of plasma total protein or albumin levels, by the 
clinical context, or by other laboratory results. Corrected calcium levels in case 
of  hypoalbuminemia can be calculated using the following formula: 
[4- patient serum albumin] * 0.8 + patient serum calcium level. 
  Acute hypocalcemia is often observed during acute hyperventilation and 
the respiratory alkalosis that follows, regardless of the cause of 
hyperventilation. Hyperventilation can occur secondary to cardiopulmonary or 
cerebral diseases. After exclusion of false hypocalcemia linked to 
hypoalbuminemia, hypocalcemia can be divided into that associated with 
elevated and that associated with low plasma phosphate concentration. 
CAUSES OF HYPOCALCEMIA 
Associated with normal/low plasma phosphate 
1. Vitamin D deficiency: decreased intake or decreased absorption 
(postgastrectomy, primary biliary cirrhosis, intestinal Ca malabsorption)  
2. Decreased 25-hydroxyvitamin D generation (liver disease, 
anticonvulsants) 
3. Decreased calcitriol formation (renal failure, type 1 vitamin D–
dependent rickets) 
4. Resistance to calcitriol (type 2 vitamin D–dependent rickets) 
5. Acute pancreatitis 
6. Magnesium deficiency 
7. Hungry bone syndrome (postsurgical treatment of 
hyperparathyroidism or vitamin D deficiency) 
Associated with high plasma phosphate 
1. Idiopathic or sporadic hypoparathyroidism 
2. Postoperative hypoparathyroidism 
3. Acquired hypoparathyroidism (postirradiation, amyloidosis) 
4. Pseudohypoparathyroidism: type 1 or 2 
5. Chronic renal failure, advanced stage 
6. Acute renal failure, oligoanuric stage 
Associated with hypoalbuminemia 
1. Hemodilution 
2. Nephrotic syndrome 
3. Exudative enteropathy 
4. Cirrhosis 
CLINICAL MANIFESTATIONS 
As with hypercalcemia, the symptoms of hypocalcemia depend on the 
rate of its development and its severity.  
1. fatigue  
2. muscle weakness 
3. increased irritability 
4. loss of memory 
5. a state of confusion 
6. hallucination, paranoia, and depression.  
Clinical signs   
1. Chovstek’s sign - tapping of facial nerve branches leads to 
twitching of facial muscle and  
2. Trousseau’s sign - carpal spasm in response to forearm ischemia 
caused by sphygmomanometer cuff. 
 In acute hypocalcemia 
1. Paresthesias of the lips and the extremities 
2. Muscle cramps 
3. Tetany 
4. Laryngeal stridor  
5. Convulsions. 
Chronic hypocalcemia  
1. Cataracts 
2. Brittle nails with transverse grooves 
3. Dry skin and  
4. Decreased or even absent axillary and pubic hair. 
Tetany, often mistaken for motor seizures, are as a result of spontaneous 
action potentials originating in peripheral nerves when the serum ionized 
calcium concentration falls below 4.3 mg/dL which usually corresponds to a 
total serum calcium concentration of 7.0-7.5 mg/dL. Tetany can also be induced 
by hypomagnesemia, hypokalemia and respiratory alkalosis. 
 
 
LABORATORY AND RADIOGRAPHIC SIGNS 
 Plasma phosphate is elevated in hypoparathyroidism, 
pseudohypoparathyroidism, and advanced CKD, whereas it is 
decreased in steatorrhea, vitamin D deficiency, acute pancreatitis, 
and the polyuric phase during recovery from AKI.  
 Plasma PTH is reduced in hypoparathyroidism and also during 
chronic magnesium deficiency, whereas it is normal or increased in 
pseudohypoparathyroidism and in CKD. 
  Urinary calcium excretion is increased only in the treatment of 
hypoparathyroidism with calcium and vitamin D derivatives, in 
which it may lead to nephrocalcinosis; it is low in all other cases of 
hypocalcemia. 
 Fractional urinary calcium excretion is high in 
hypoparathyroidism,in the polyuric phase during recovery from 
AKI, and in severe CKD; it is low in all other cases of 
hypocalcemia. 
 Urinary phosphate excretion is low in hypoparathyroidism, 
pseudohypoparathyroidism, and magnesium deficiency; it is high 
in vitamin D deficiency, steatorrhea, and CKD and during 
phosphate administration. Determination of serum 25-
hydroxyvitamin D and calcitriol levels may also be useful. 
 Intracranial calcifications, notably of the basal ganglia, are 
observed radiographically in 20% of patients with idiopathic 
hypoparathyroidism but much less frequently in patients with 
postsurgical hypoparathyroidism or pseudohypoparathyroidism. 
 On electrocardiography, the corrected QT interval is frequently 
prolonged, and there are sometimes arrhythmias.  
 Electroencephalography shows nonspecific signs, such as an 
increase in slow, high-voltage waves. 
TREATMENT 
 The basic treatment is that of the underlying cause. 
 Severe and symptomatic (tetany) hypocalcemia requires rapid 
treatment. 
 Acute respiratory alkalosis, if present, should be corrected, if 
possible.  
 When the cause is functional, the simple retention of carbon 
dioxide (e.g., by breathing into a paper bag) may suffice.  
 In other cases and to obtain a prolonged effect, intravenous 
infusion of calcium salts is most often required. 
  In the setting of seizures or tetany, calcium gluconate should be 
administered as an intravenous bolus (for instance, calcium 
gluconate, 10 ml 10% w/v [2.2 mmol of calcium], diluted in 50 ml 
of 5% dextrose or isotonic saline), followed by 12 to 24 g during 
24 hours in 5% dextrose or isotonic saline. Calcium gluconate is 
preferred to calcium chloride, which can lead to extensive skin 
necrosis in accidental extravasation. 
 Treatment of chronic hypocalcemia includes oral administration of 
calcium salts, thiazide diuretics, or vitamin D. Several oral 
preparations of calcium are available, each with its advantages and 
disadvantages. The amount of elemental calcium of the various 
salts differs greatly. For example, the calcium content is 40% in 
carbonate, 36% in chloride, 12% in lactate, and only 8% in 
gluconate salts.  
 The daily amount prescribed can be 2 to 4 g elemental calcium. 
Concurrent magnesium deficiency (serum Mg2+ <0.75 mmol/l) 
should be treated either with oral magnesium oxide (250 to 500 mg 
every 6 days) or with magnesium sulfate: intramuscular (4 to 8 
mmol/day) or intravenous (2 g i.v. over 2-4 hours, then as needed 
to correct deficiency). 
 Treatment of hypocalcemia secondary to hypoparathyroidism is 
difficult as urinary calcium excretion increases markedly with 
calcium supplementation and can lead to nephrocalcinosis and loss 
of renal function. To reduce urinary calcium concentration, 
thiazide diuretics can be used in association with restricted salt 
intake and high fluid intake. 
 Lastly, treatment with active forms of vitamin D, calcitriol or its 
analogue 1α-hydroxycholecalciferol (0.25 to 1.0 μg/day), is the 
treatment of choice at present for idiopathic or acquired 
hypoparathyroidism because these compounds are better tolerated 
than massive doses of calcium salts. Administration of vitamin D 
derivatives generally leads to hypercalciuria and, rarely, to 
nephrocalcinosis. It requires regular monitoring of the serum 
calcium concentration to avoid hypercalcemia. 
MAGNESIUM HOMEOSTASIS 
 Magnesium is the fourth most abundant cation in the body and the second 
most abundant cation intracellularly. It is often referred to as the “forgotten 
cation “. Magnesium plays a vital role in many functions of the cell including 
protein, carbohydrate and fat metabolism , maintenance of normal cell 
membrane function and most importantly the regulation of parathyroid hormone 
secretion. It is involved in the regulation of mitochondrial function, 
inflammatory processes and immune defence, allergy, growth, and stress, and in 
the control of neuronal activity, cardiac excitability, neuromuscular 
transmission, vasomotor tone, and blood pressure. 
 
HYPOMAGNESEMIA AND MAGNESIUM DEFICIENCY 
 Magnesium deficiency is defined as a decrease in total body magnesium 
content. Poor dietary intake of magnesium is usually not associated with marked 
magnesium deficiency because of the remarkable ability of the normal kidney to 
conserve Mg2+.Hypomagnesemia is encountered in about 25% to 35% of 
patients with acute pancreatitis, is frequently observed in patients with chronic 
alcoholism, and can also be present in patients with poorly controlled diabetes 
mellitus. Hypomagnesemia can also be observed in patients with hypercalcemic 
disorders and in primary aldosteronism. 
ETIOLOGY 
Decreased intake 
 Starvation 
 Alcohol dependence 
 Total parenteral nutrition 
Gastrointestinal diseases 
 Malabsorption syndromes - nontropical sprue, steatorrhea 
 Massive resection of the small intestine  
 Intestinal and biliary fistulae 
 Excessive use of purgatives 
 
Increased urinary losses 
 Drug administration – Aminoglycoside, Amphotericin, Cisplatin, 
Cyclosporine, Pentamidine, Thiazide diuretics 
 High urinary output states (polyuric phase of acute renal failure, 
postobstructive polyuria ,post-transplantation polyuria) 
 Hypercalcemic states 
 Primary aldosteronism 
 Metabolic acidosis 
 Diabetes (glycosuric and ketoacidotic states) 
 Hyperthyroidism 
 Phosphate depletion 
 Idiopathic renal wasting 
 Gitelman’s syndrome 
Miscellaneous 
 Acute pancreatitis 
 Chronic alcoholism 
 Bartter syndrome 
 Idiopathic hypomagnesemia 
 
 
CLINICAL MANIFESTATIONS 
Specific clinical manifestations of hypomagnesemia may be difficult to 
appreciate because of concomitant hypocalcemia and hypokalemia.  
Moderate to severe magnesium depletion causes 
 General weakness , 
 Neuromuscular hyperexcitability with hyperreflexia , 
 Carpopedal spasm, 
  Seizure,  
 Tremor, 
  tetany.  
Cardiac findings 
 prolonged QT interval and ST depression 
 predisposition to ventricular arrhythmias  
 potentiation of digoxin toxicity. 
Magnesium deficiency can also be associated with hypocalcemia (decreased 
PTH release and end-organ responsiveness) and hypokalemia (urinary loss).The 
diagnosis of moderate degrees of magnesium deficiency is not easy because 
clinical manifestations may be absent and blood Mg2+ levels may not reflect 
the state of body magnesium. Severe magnesium deficits, however, are 
associated with hypomagnesemia. 
TREATMENT 
Magnesium deficiency is managed with the administration of magnesium 
salts. Magnesium sulfate is generally used for parenteral therapy (1500 to 3000 
mg [150 to 300 mg elemental magnesium] per day). A variety of magnesium 
salts are available for oral administration, including oxide, hydroxide, sulfate, 
lactate, chloride and carbonate. Oral magnesium salts often are not well 
tolerated. All of them may induce gastrointestinal intolerance, in particular 
diarrhea. 
Green vegetables such as spinach are good sources of magnesium. Some 
legumes (beans and peas), nuts and seeds, and whole, unrefined grains are also 
good sources of magnesium. 
 
 
 
 
 
 
 
 
 
METHODS AND MATERIALS 
Study group            
 Case        :  Patients with alcohol related seizures satisfying CAGE 
criteria.  
 Control   :  Patients with primary idiopathic seizures. 
Study design                              :        Analytical case control study 
                                                             (Cross sectional study) 
Place of Study    :  Govt. Royapettah Hospital 
Duration of study    : 6 months 
Conflict of interest           :         Nil. 
Hazards of study                       :        Nil 
 
METHODOLOGY 
This study was formulated as an analytical case control study.  Ethical 
committee approval was obtained from Institutional Ethical Committee, 
Kilpauk Medical College, Chennai-10. This study was conducted in 
Government Royapettah hospital in the department of General Medicine 
between May and December 2013. 
 Patients presenting with seizures to the emergency department were 
screened after obtaining written informed consent.  
Inclusion criteria : 
Case      : Patients (with age >18 yrs) satisfying CAGE criteria of alcohol          
dependence and who had seizures. 
Control  : Patients (with age >18 yrs) with primary idiopathic seizures  
Exclusion criteria : 
 Patients with 
1. Previous head injury 
2  Metabolic diseases 
3. Stroke 
4. Structural brain lesions 
5.CNS infections 
6.Other illicit drugs 
Based on previous records and by obtaining past history of any CNS 
infections, cerebrovascular accidents, head injury, structural brain lesions, 
metabolic diseases and illicit drug abuse ,patients with all negative history were 
screened  with investigations such as serum electrolytes, random blood sugar 
,serum amylase, serum bilirubin  and CT- brain . Among these patients, patients 
who had all values within normal limits were taken into study population. 
Among the patients in study population, patients with no history of 
alcohol consumption with all screening blood investigations within normal 
limits and those with EEG and CT Brain findings suggestive of primary seizures 
were grouped into control population. Patients satisfying CAGE criteria with 
screening blood investigations and CT-Brain normal were grouped into case 
population. Then, serum calcium levels, serum albumin levels and serum 
magnesium levels were measured in both cases and controls. Corrected calcium 
will be calculated in case of hypoalbuminemia. Patients with serum calcium 
levels between 8.7 - 10.2 mg/dl were taken as normal. Patients with levels 8.6 
md/dl or less were taken as hypocalcemic range and 10.3 mg/dl and above as 
hypercalcemic range. Serum calcium levels were compared in both cases and 
controls. The prevalence of hypomagnesemia in these patients and their 
association with hypocalcemia were also assessed secondarily. The results were 
tabulated and their statistical significance were calculated using pearson’s chi 
square tests.      
 
 
 
RESULTS 
Total of 182 patients presenting with seizures in the emergency 
department were screened. Total of 110 patients were taken into study 
population and 72 patients were excluded due to other causes . 
Of the 110 patients 56 were grouped into cases and 54 into control group. 
 
Fig 8 : Study population 
DESCRIPTIVE STATISTICS 
 The mean age of the case group is 42.821 years (min 29 yrs and 
max 53 yrs). The mean age of the control group is 40.574 years (min 17 yrs and 
max 55 yrs) 
182patients 
56 cases 54 controls 
72 
excluded 
  N Minimum Maximum Mean 
Case 56 29 53 42.821 
Control 54 17 55 40.574 
Table 6 : Mean age of study population 
                                                           
  
Among the cases and controls all patients included in the study group had 
normal levels of random blood sugar, serum sodium, serum potassium, serum 
amylase , serum bilirubin and CT brain.  
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Chart 1: Age wise distribution of study 
population 
In the case group the mean RBS was 110.310 , mean serum sodium – 
139.8 , mean S.potassium – 3.978, mean S.amylase -51.035 and mean serum 
bilirubin was 0.7. in the control group the mean values of RBS, S.sodium, 
S.potassium, S.amylase and S,bilirubin were 111.592, 138.259, 4.064, 42.296 
and 0.659  respectively. 
 CASE CONTROL MEAN 
MIN MAX MIN MAX CASE CONTROL 
RBS 80 152 80 163 110.310 111.592 
Serum sodium 135 145 135 145 139.8 138.259 
Serum potassium 3.5 4.9 3.5 4.9 3.978 4.064 
Serum bilirubin 0.3 1.1 0.3 1.1 0.7 0.659 
Serum amylase 24 90 26 72 51.035 42.296 
Table 7 : Mean lab values of study population 
The mean calcium values in the case and control population were 9.200 
and 9.065 respectively 
 Group N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Serum 
Calcium 
Control 
54 9.065 .4149 .0565 
Cases 
56 9.200 .5530 .0739 
Table 8 : Mean serum calcium values of study population 
The mean magnesium values in the case and control population were 
1.791 and 1.798 respectively. 
 
 Group N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Serum 
Magnesium 
Control 
54 1.798 .4708 .0641 
Cases 
56 1.791 .2776 .0371 
Table 9: Mean serum magnesium values of study population 
 
There is no significant difference in the mean serum calcium and 
magnesium levels among cases and controls. 
calcium magnesium 
case 9.2 1.791 
control 9.065 1.798 
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Chart 2: Mean calcium and magnesium levels 
among cases and controls 
In the case group out of 56 patients , 39 patients had normal calcium 
level, 15 were in hypocalcemic range and 2  had hypercalcemia. Thus, about 
26.8 % of the cases were in hypocalcemic range, 69.6% in normocalcemic 
range and 3.6% in hypercalcemic range.  
In the control group of 54 patients , the number of patients in 
normocalcemic, hypocalcemic and hypercalcemic range were respectively 45,8 
and 1. The percentage of patients presenting with hypo, normo and 
hypercalcemic range within the control group were 14.8 %, 83.3 % and 1.9 % 
respectively. 
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cases 15 39 1.8 
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Chart 3: Serum calcium levels among controls 
and cases 
  
Group 
Total Control Cases 
 
 
 
 
 
 
 
 
Serum 
Calcium 
Hypo Count 8 15 23 
% within 
Serum 
Calcium 
34.8% 65.2% 100.0% 
% within 
Group 
14.8% 26.8% 20.9% 
Normal Count 45 39 84 
% within 
Serum 
Calcium 
53.6% 46.4% 100.0% 
% within 
Group 
83.3% 69.6% 76.4% 
Hyper Count 1 2 3 
% within 
Serum 
Calcium 
33.3% 66.7% 100.0% 
% within 
Group 
1.9% 3.6% 2.7% 
Total Count 54 56 110 
Table 10 : Comparison of serum calcium values in cases and controls 
CHI-SQUARE TESTS 
 Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 2.857(a) 2 .240 
Likelihood Ratio 2.897 2 .235 
Linear-by-Linear 
Association 
1.408 1 .235 
N of Valid Cases 
110   
 
  On comparing the case and control group , 65.2 % of the hypocalcemic 
patients were in the case group. Only  34.8 % of the patients were in the control 
group. On applying the chi-square tests, the p value is found to be 0.240. Thus, 
there is no statistically significant difference in the prevalence of hypocalcemia 
among the case and control group.  
  
Group 
Total Control Cases 
 
 
 
Serum 
Magnesium 
Hypo Count 5 10 15 
% within 
Group 
9.3% 17.9% 13.6% 
Normal Count 48 46 94 
% within 
Group 
88.9% 82.1% 85.5% 
Hyper Count 1 0 1 
% within 
Group 
1.9% .0% .9% 
Total Count 54 56 110 
 
Table 11 : Comparison of serum magnesium values in cases and controls 
 
hypo normal hyper 
control 5 48 1 
case 1 46 0 
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Chart 4 : Serum magnesium levels among 
control and cases 
The prevalence of hypomagnesemia in the case and control group is 17.9 
% and 9.3 % respectively. On applying the chi-square test, the p value is 0.263 
which is >0.05, thus there is no statistical difference in the prevalence of  
hypomagnesemia among cases and control. 
 
Group   Serum Magnesium Total 
  Hypo Normal Hyper   
 
 
 
 
 
Control 
  
  
  
 
 
Serum 
Calcium 
  
  
Hypo 
2 6 0 8 
Normal 
3 41 1 45 
Hyper 
0 1 0 1 
 Total 
5 48 1 54 
 
 
 
 
 
Cases 
  
  
  
 
 
Serum 
Calcium 
  
  
Hypo 
6 9 0  15 
Normal 
4 35 0  39 
Hyper 
0 2 0  2 
Total 
10 46 0  56 
 
Table 12 : Comparison of serum calcium and serum magnesium levels 
On comparing the prevalence of hypomagnesemia among hypocalcemic 
patients in the case group, the p value is found to be 0.03 which is statistically 
significant. 
 Among controls the p-value is 0.562 , thus the prevalence of 
hypomagnesemia among hypocalcemic patients is statistically insignificant. 
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Chart 5: Comparison of serum magnesium 
and calcium levels among controls 
hypo normal hyper 
hypo 6 4 3.5 
normal 9 35 2 
hyper 0 0 0 
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Chart 6: Comparison of serum magnesium 
and calcium levels among cases 
Among the 72 patients excluded  from the study, 51 patients satisfied 
CAGE criteria and 21 patients were non alcoholics. Among the alcoholics , the 
most common cause of seizures was found to be metabolic (hypoglycaemia) 
and among the nonalcoholics previous cerebrovascular accident was the 
common cause.  
 
 
Chart 7: Etiology of seizures in Alcoholics in 
excluded population 
previous head injury 
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Chart 8 : Etiology of seizures in Non-
Alcoholics in excluded population 
metabolic 
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DISCUSSION 
   
It is a well known fact since Hippocratic times that ethanol overuse 
produces seizures. Alcohol related seizures may be either due to alcohol 
intoxication or alcohol withdrawal. Alcohol related seizures accounts for about 
one third of seizure related admissions. Seizures occur in alcoholics as an effect 
of alcohol intoxication or alcohol withdrawal. The diagnosis of alcohol related 
seizures is primarily based on history taking and examination. The concurrent 
risk factors in these group of patients are pre-existing epilepsy, structural brain 
lesions , head injury, metabolic diseases and use of illicit drugs. 
 It is also known fact that various electrolyte abnormalities can lead to 
seizures , especially hypocalcemia. In the study conducted by Gordon et al, it 
has  been proven that alcohol can interfere with calcium metabolism in several 
ways, acute alcohol consumption causes transient parathormone deficiency and 
increases the urinary calcium excretion , resulting in calcium loss from the 
body. Chronic alcohol abuse causes disturbance in vitamin D metabolism 
producing inadequate dietary calcium absorption.  
The purpose of this study is to find the prevalence of hypocalcemia 
among alcohol related seizures after excluding the secondary causes of seizures 
and after excluding other electrolyte abnormalities and to compare with  
primary seizures disorder patients who were not alcoholics . Hypocalcemia as a 
cause of seizure in neonates is well documented whereas hypocalcemia as a 
cause of seizures in adults is still underestimated. The study also aims  to find 
the prevalence of hypocalcemia in seizure patients due to any cause after 
excluding other electrolyte abnormalities. Other factors responsible for 
provoking seizures in alcoholics were also analysed . 
In a study conducted by kayath et al , it was proven that hypocalcemia is 
an important factor in the alcoholic convulsive population. As ethanol reduces 
both calcium and magnesium levels . a high prevalence of hypocalcemia was 
found in alcoholic convulsive population in contrast with the non alcoholic 
convulsive group and alcoholic non convulsive group. This study emphasized 
the importance of serum calcium measurement in alcoholic seizure patients and 
suggested that  hypocalcemia correction may be considered in these patients. 
In this study a total of 182 seizure patients were screened in the 
emergency department of which 72 were excluded from the study due to 
secondary causes and the presence of other biochemistry abnormalities. Among 
the 110 patients in study population, 56 patients satisfied CAGE questionnaire 
of alcohol dependence and were grouped as cases. Rest 54 patients were non 
alcoholic primary seizure patients and were grouped as controls. Among 72 
excluded patients , 51 satisfied CAGE criteria. Of the population screened in 
our emergency department ,58.791% of patients were alcohol dependent 
and 41.208% of patients were non alcoholics . Thus , nearly half of the 
patients admitting with seizures in our hospital are either alcohol related 
seizures or seizure disorder patient with habit of alcohol abuse.  
The prevalence of hypocalcemia among the case was 26.8% and among 
the control was 14.8%. Though there was no statistical significance in 
hypocalcemia among cases and controls, the prevalence of hypocalcemia in 
alcoholic seizures were found to be high. Nearly one fourth of the alcohol 
related seizures had hypocalcemia in our study. The prevalence of 
hypocalcemia among the total study population is found to be 20.909%. 
The prevalence of hypomagnesemia in hypocalcemic patients among 
cases was found to be 40% and among controls was 25%. In the alcohol related 
seizures the prevalence of hypomagnesemia in hypocalcemic group was 
statistically significant. Thus, the measurement of serum magnesium level 
along with serum calcium level is of added significance. It is known that the 
correction of hypocalcemia alone is not enough without correcting the serum 
magnesium levels. Hypomagnesemia itself is an independent risk factor for 
seizures. 
Among the excluded patients, the most common cause of  alcohol related 
seizures were found to be metabolic, more specifically hypoglycaemia. The 
common cause among non alcoholics were found to be previous 
cerebrovascular accident. 
Thus, this study had proven the increased prevalence of hypocalcemia 
among alcohol related seizures and also an increased prevalence of 
hypomagnesemia in this population. Further studies are needed to check the 
correlation of hypocalcemia with other electrolyte abnormalities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS 
 
 This study was conducted in a very small population. Further studies in a 
larger population is recommended. 
 Ionised calcium levels which indicates the functional form of calcium 
were not measured, only the serum calcium levels were measured. 
 Correlation of the calcium level with parathormone level was not 
measured. 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 The burden of alcohol related health problems are often 
underestimated in developing countries .This study emphasizes the 
high incidence of alcohol related admissions to the emergency 
department presenting as seizures.  
 Several aetiologies for alcohol related seizures has been postulated. 
Most common among them are the electrolyte abnormalities. This 
study was done in view of identifying the common electrolyte 
disturbance , Hypocalcemia as a cause of seizures in these group of 
patients.  
 A high prevalence of Hypocalcemia among alcohol related 
seizures were identified in this study ,though a statistical 
significance against primary seizures could not be proven.  
 The prevalence of Hypomagnesemia was statistically 
significant in the Hypocalcemic alcoholic patients. Thus, 
hypomagnesemia as a cause of seizures in these patients needs 
further studies.  
 If Hypocalcemia and Hypomagnesemia as a cause of Alcohol 
related seizures could be proved on further studies , inclusion of 
Calcium  and Magnesium as a treatment modality for alcohol 
related seizures could be considered. 
 
DISCLOSURE 
The investigator has not received any form of grants or support from any 
institution or pharmacological company. 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
1. Messing RO, Simon RP. Seizures as a manifestation of systemic disease. 
Neurol Clin 1986;4:563-584. 
2. Tohme JF, Bilezikian JP. Hypocalcemic emergencies. Endocrinol Metab 
Clin North Am 1993;22:363-375. 
3. Fonseca OA, Calverley JR. Neurological manifestations of 
hypoparathyroidism. Arch Intern Med 1967;120:202-206. 
4. Gupta MM. Medical emergencies associated with disorders of calcium 
homeostasis. J Assoc Physicians India 1989;37:629-631. 
5. Lloyd G . Hippocratic Writings . Middlesex, UK : Penguin Books , 1978 ; 
p. 222 
6. Rathlev NK, Ulrich AS, Fish SS, D’Onofrio G. Clinical characteristics as 
predictors of recurrent alcohol-related seizures. Acad Emerg Med 
2000;7:886 –91. 
7. Reynolds EH. The ILAE/IBE/WHO Global Campaign against Epilepsy: 
Bringing Epilepsy “Out of the Shadows” Epilepsy Behav. 2000;1:S3–S8. 
8. 2. Epigraph WHO. The newsletter of the International League against 
Epilepsy. Geneva. 1999;1:5–6. 
9. WHO,Factsheet999,epilepsy, 
www.who.int/mediacentre/factsheets/fs999/en/index.html  accessed 1 
June 2010 
10. Ministry of Health & Family Welfare,Government of India, integrated 
disease surveillance project (idsp) non-communicable disease risk factors 
survey 2007-08 Tamil Nadu 
11. Feuerlein, W., Alkoholismus — Mißbrauch und Abhaengigkeit, Thieme, 
Stuttgart, 1989. 
12. Victor, M., The effects of alcohol on the nervous system, Medical 
Diagnosis and Treatment of Alcoholism, Mendelson, J.H. and Mello, 
N.K., Eds., McGraw-Hill, New York, 1992, 201. 
13. Victor, M. and Laureno, R., The neurologic complications of alcohol 
abuse: Epidemiologic aspects,Advances in Neurology, Vol. 19. 
Neurological Epidemiology: Principles and Clinical 
Applications,Schoenberg, B.S., Ed., Raven, New York, 1978, 603. 
14. Juvela, S., Alcohol consumption as a risk factor for poor outcome after 
aneurysmal subarachnoidal hemorrhage, Br. Med. J., 304, 1663, 1992. 
15. Klatzky, A.L., Friedmann, G.D., Siegelaub, A.N., and Gerard, M.J., 
Alcohol consumption and blood pressure. Kaiser-Permanente multiphase 
health examination data, N. Engl. J. Med., 296, 1194, 1977. 
16. Calandre, L., Arenal, C., Fernandez Ortega, J., and Vallejo A., Risk 
factors for spontaneous cerebral hematomas. Case control study, Stroke, 
17, 1226, 1986 
17. Sacco, R.L., Elkind, M., and Boden-Albala, B., The protective effect of 
moderate alcohol consumption on ischemic stroke, JAMA, 281, 53, 1999. 
18. Verfaellie, M. and Cermak, L.S., Wernicke-Korsakoff and related 
nutritional disorders of the nervous system, Behavioural Neurology and 
Neuropsychology, Feinberg, T.E. and Farah, M.J., Eds., McGraw-Hill, 
New York, 1997, 606. 
19. Sullivan, Edith V.; Fama, Rosemary (2012). "Wernicke's Encephalopathy 
and Korsakoff's Syndrome Revisited". Neuropsy chology Review 22 (2): 
69–71 
20. Charness, M.E. and DeLaPaz, R.L., Mammillary body atrophy in 
Wernicke encephalopathy: antemortem identification using MRI, Ann. 
Neurol., 22, 595, 1987. 
21. Reuler, J.B., Girard, D.E., and Cooney, T.G., Wernickes’s 
encephalopathy, N. Engl. J. Med., 312, 1035,1985. 
22. Grant, B. F., Alcohol consumption, alcohol abuse and alcohol 
dependence: the United States as an example, Addiction, 89, 1357, 1994. 
23. Stuppaeck, C.H., Pycha, R., Miller, C., Whitworth, A.B., Oberbauer, H., 
and Fleischhacker, W.W.,Carbamazepine versus oxazepam in the 
treatment of alcohol withdrawal: a double-blind study, Alcohol Alcohol., 
27, 153, 1992. 
24. Stuppaeck, C.H., Barnas, C., Hackenberg, K., Miller, C., and 
Fleischhacker, W.W., Carbamazepine monotherapy in the treatment of 
alcohol withdrawal, Int. Clin. Psychopharmacol., 5, 273, 1990. 
25. Ballenger, J.C. and Post, R.M., Kindling as a model for alcohol 
withdrawal syndromes, Br. J.Psychiatry, 133, 1, 1978. 
26. Sullivan, J.T., Sykora, K., Schneiderman, J., Naranjo, C.A., and Sellers, 
E.M., Assessment of alcohol withdrawal: the revised clinical institute 
withdrawal assessment for alcohol scale (CIWA-Ar), Br. J. Addict., 84, 
1353, 1989. 
27. Saitz, R. and O’Malley, S.S., Pharmacotherapies for alcohol abuse. 
Withdrawal and treatment, Alcohol and Other Substance Abuse, 81, 881, 
1997. 
28. Mayo-Smith, M.F., Pharmacological management of alcohol withdrawal. 
A meta-analysis and evidence-based practice guide, JAMA, 278, 144, 
1997. 
29. Kaim, S.C., Klett, C.J., and Rothfeld, B., Treatment of the acute 
withdrawal state: a comparison of four drugs, Am. J. Psychiatry, 125, 
1640, 1969. 
30. Mayo-Smith, M.F. and Bernard, D., Late-onset seizures in alcohol 
withdrawal, Alcohol Clin. Exp.Res., 19, 656, 1995. 
31. Pycha, R., Miller, C., Barnas, C., Hummer, M., Stuppaeck, C., 
Whitworth, A., and Fleischhacker,W.W., Intravenous flunitrazepam in 
the treatment of alcohol withdrawal delirium, Alcohol Clin. Exp.Res., 17, 
753, 1993. 
32. Kuhn, R., The psychotropic effect of carbamazepine in non-epileptic 
adults with particular reference to the drug mechanism of action, 
Epileptic Seizures, Behaviour and Pain, Birkmayer, W., Ed.,University 
Park Press, Baltimore, 1976. 
33. Vamvakas S, Teschner M, Bahner U, Heidland A: Alcohol abuse: 
Potential role in electrolyte disturbances and kidney diseases. Clin 
Nephrol 1998;49:205–213. 
34. Wrenn KD, Slovis CM, Minion GE, Rutkowski R: The syndrome of 
alcoholic ketoacidosis.Am J Med 1991;91:119–128. 
35. De Marchi S, Cecchin E, Basile A, Bertotti A,Nardini R, Bartoli E: Renal 
tubular dysfunction in chronic alcoholic abuse – Effects of abstinence. N 
Engl J Med 1993;329:1927–1934. 
36. Shils ME: Magnesium, calcium and parathyroid interaction. Ann NY 
Acad Sci 1980;355:165–178 
37. Parenti P, Giorbana B, Hanozet GM: In vitro effect of ethanol on sodium 
and glucose transport in rabbit renal brush border membrane vesicles. 
Biochim Biophys Acta 1991;1070:92–98. 
38. Laitinen K, Lamberg-Allardt C, Tunninen R,Karonen SL, Tähtelä R, 
Ylikahri R, Välimäki M: Transient hypoparathyroidism during acute 
alcohol intoxication. N Engl J Med 1991;324:721–727. 
39. Krapf R, Jaeger P, Hulter HN: Chronic respiratory alkalosis induces renal 
PTH resistance,hyperphosphatemia and hypocalcemia in humans.Kidney 
Int 1992;42:727–734. 
40. Gascon-Barre M: Interrelationships between vitamin D3 and 25-
hydroxyvitamin D3 during chronic ethanol administration in the rat. 
Metabolism 1982;31:67–72. 
41. Ewing, J.A., Detecting alcoholism: the CAGE questionnaire, JAMA, 252, 
1905, 1984. 
42. Babor, T.F., Hofman, M., Delboca, F.K, Hesselbrock, V., Meyer, R.E., 
Dolinsky, Z.S., and Rounsaville,B., The Alcohol Use Disorder Test: 
Guidelines for Use in Primary Health Care. WHO Publication No. 89.4, 
World Health Organization, Geneva, 1989. 
43. Saunders, J.B., Aasland, O.G., Babor, T.F., de la Fuente, J.R., and Grant, 
M., Development of the Alcohol Use Disorders Identification Test 
(AUDIT): WHO collaborative project on early detection of persons with 
harmful alcohol consumption. II, Addiction, 88, 791, 1993. 
44. Aertgeerts B , Buntinx F , Ansoms S , Fevery J . Questionnaires are better 
than laboratory tests to screen for current alcohol abuse or dependence in 
a male inpatient population . Acta Clin Belg 2002 ; 57 : 241 – 9 . 
45. Bernadt MW , Mumford J , Taylor C , Smith B , Murray RM 
.Comparison of questionnaire and laboratory tests in the detection of 
excessive drinking and alcoholism . Lancet 1982 ; i : 325 – 8 . 
46. Bråthen G , Bjerve K , Brodtkorb B , Bovim G . Validity of carbohydrate 
- defi cient transferrin and other markers as diagnostic aids in the 
detection of alcohol - related seizures .J Neurol Neurosurg Psychiatry 
2000 ; 68 : 342 – 8 . 
47. Martin MJ , Heyermann C , Neumann T , et al . Preoperative evaluation 
of chronic alcoholics assessed for surgery of the upper digestive tract . 
Alcohol Clin Exp Res 2002 ;26 : 836 – 40 . 
48. Sorvajarvi, K., Blake, J.E., Israel, Y., and Niemela, O., Sensitivity and 
specificity of carbohydrate  deficient transferrin as a marker of alcohol 
abuse are significantly influenced by alterations in serum transferrin: 
comparison of two methods, Alcohol Clin. Exp. Res., 20, 449, 1996. 
49. Bråthen G , Bjerve K , Brodtkorb B , Bovim G . Validity of carbohydrate 
- defi cient transferrin and other markers as diagnostic aids in the 
detection of alcohol - related seizures .J Neurol Neurosurg Psychiatry 
2000 ; 68 : 342 – 8 . 
50. Hietala J , Koivisto H , Anttila P , Niemelä O . Comparison of  the 
combined marker GGT - CDT and the conventional laboratory markers of 
alcohol abuse in heavy drinkers,moderate drinkers and abstainers . 
Alcohol Alcohol 2006 ; 41 : 528 – 33 . 
51. Bentele M , Kriston L , Clement HW , Härter M , Mundle G ,Berner MM 
. The validity of the laboratory marker combinations DOVER and 
QUVER to detect physician ’ s diagnosis of at- risk drinking . Addict Biol 
2007 ; 12 : 85 – 92 
52. Sillanaukee P , Olsson U . Improved diagnostic classification of alcohol 
abusers by combining carbohydrate – deficient transferrin and G- 
glutamyltransferase. Clin Chem 2001 ;47 : 681 – 5 
53. Savola O , Niemel ä O , Hillbom M . Blood alcohol is the best indicator 
of hazardous alcohol drinking in young adults and working aged patients 
with trauma . Alcohol Alcohol 2004 ; 39 : 340 – 5 . 
54. 74. Sullivan JT , Sykora K , Schneiderman J , Naranjo CA , Sellers EM 
. Assessment of alcohol withdrawal: the revised Clinical Institute 
Withdrawal Assessment for Alcohol scale (CIWA -AR) . Br J Addict 
1989 ; 84 : 1353 – 7 . 
55. Earnest MP , Feldman H , Marx JA , Harris BS , Biletch M ,Sullivan LP . 
Intracranial lesions shown by CT in 259 cases of fi rst alcohol related 
seizure . Neurology 1988 ; 38 : 1561 . 
56. Schoenenberger RA , Heim SM . Indication for computed tomography of 
the brain in patients with fi rst uncomplicated generalised seizure . BMJ 
1994 ; 309 : 986 – 9 
57. Hillbom ME , Hjelm - Jaeger M . Should alcohol withdrawal seizures be 
treated with anti - epileptic drugs? Acta Neurol Scand 1984 ; 69 : 39 – 2 . 
58. Holzbach E . Thiamine absorption in alcoholic delirium patients . J 
Studies Alcohol 1996 ; 57 : 581 – 4 . 
59. Day E , Bentham P , Callaghan R , Kuruvilla T , George S . Thiamine for 
Wernicke - Korsakoff Syndrome in people at risk from alcohol abuse. 
Cochrane Database of Systematic Reviews 2004 ;( 1 ):Art. No.: 
CD004033. DOI: 10.1002/14651858.CD004033.pub2. 
60. Mochizuki H , Masaki T , Miyakawa T , et al . Benign type of central 
pontine myelinolysis in alcoholism: clinical, neuroradiological and 
electrophysiological fi ndings . J Neurol 2003 ; 250 : 1077 – 83 . 
61. Kelly J , Wassif W , Mitchard J , Gardner WN . Severe hyponatremia 
secondary to beer potomania complicated by central pontine myelinolysis 
. Int J Clin Pract 1998 ; 52 : 585 – 7 . 
62. Saeed BO , Beaumont D , Handley GH , Weaver JU . Severe 
hyponatremia: investigation and management in a district general hospital 
. J Clin Pathol 2002 ; 55 : 893 – 6 . 
63. Lampl C , Yazdi K . Central pontine myelinolysis. Eur Neurol 2002 ; 47 ( 
1 ): 3 – 10 . 
64. Victor M . The role of hypomagnesemia and respiratory alkalosis in the 
genesis of alcohol withdrawal symptoms .Ann NY Acad Sci 1973 ; 215 : 
235 – 48 . 
65. Traviesa DC . Magnesium defi ciency: a possible cause of thiamine 
refractoriness in Wernicke - Korsakoff encephalopathy . J Neurol 
Neurosurg Psychiatry 1974 ; 37 : 959 – 62 . 
66. Hillbom M , Pieninkeroinen I , Leone M . Seizures in alcoholdependent 
patients. Epidemiology, pathophysiology and management. CNS Drugs 
2003 ; 17 : 1013 – 30 . 
67. D ’ Onofrio G , Rathlev NK , Ulrich AS , Fish SS , Freedland ES 
.Lorazepam for the prevention of recurrent seizures related to alcohol . N 
Engl J Med 1999 ; 340 : 915 – 9 . 
68. Hillbom ME , Hjelm - Jaeger M . Should alcohol withdrawal seizures be 
treated with anti - epileptic drugs? Acta Neurol Scand 1984 ; 69 : 39 – 2 . 
69. Malcolm R , Myrick H , Brady KT , Ballenger JC . Update on 
anticonvulsants for the treatment of alcohol withdrawal . Am J Addict 
2001 ; 10 (Suppl.): 16 – 23. 
70. Mueller TI , Stout RL , Rudden S , et al . A double- blind,placebo - 
controlled pilot study of carbamazepine for the treatment of alcohol 
dependence . Alcohol Clin Exp Res 1997 ; 21 ( 1 ): 86 – 92 . 
71. Brower KJ , Myra Kim H , Strobbe S , Karam - Hage MA ,Consens F , 
Zucker RA . A randomized double- blind pilot trial of gabapentin versus 
placebo to treat alcohol dependence and comorbid insomnia . Alcohol 
Clin Exp Res 2008 ; 32 ( 8 ): 1429 – 38 . 
72. Salloum IM , Cornelius JR , Daley DC , Kirisci L , Himmelhoch JM , 
Thase ME . Effi cacy of valproate maintenance inpatients with bipolar 
disorder and alcoholism: a double -blind placebo - controlled study . Arch 
Gen Psychiatry 2005 ;62 ( 1 ): 37 – 45 . 
73. Martinotti G , Di Nicola M , Tedeschi D , Mazza M , Janiri L ,Bria P . 
Effi cacy and safety of pregabalin in alcohol dependence. Adv Ther 2008 
; 25 ( 6 ): 608 – 18 . 
74. Johnson BA , Rosenthal N , Capece JA , et al . Topiramate for 
Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. 
Topiramate for treating alcohol dependence:a randomized controlled trial 
. JAMA 2007 ; 298 ( 14 ):1641 – 51 . 
75. Wasserman RH, Chandler JS, Meyer SA, et al. Intestinal calcium 
transport and calcium extrusion process at the basolateral membrane. J 
Nutr. 1992;122:662-671. 
76. Wasserman RH, Fullmer CS. Vitamin D and intestinal calcium transport: 
Facts, speculations and hypotheses. J Nutr. 1995;125: 1971S-1979S. 
77. Kinyamu HK, Gallagher C, Prahl JM, et al. Association between 
intestinal vitamin D receptor, calcium absorption, and serum 1,25 
dihydroxyvitamin D in normal young and elderly women. J Bone Miner 
Res.1997;12:922-928.  
78. Martin T, Gooi JH, Sims NA. Molecular mechanisms in coupling of bone 
formation to resorption. Crit Rev Eukaryot Gene Expr. 2009;19:73-88. 
PROFORMA 
 
NAME:                    AGE:              SEX: 
ADDRESS:        
PRESENT HISTORY: 
CAGE QUESTION: 
Cut down              :          Y/N 
Annoyed               :           Y/N 
Guilty                    :           Y/N 
Eye opener          :            Y/N 
 
PAST HISTORY: 
TREATMENT HISTORY: 
PERSONAL HISTORY: 
CLINICAL EXAMINATION: 
CVS  :                                                                               RS: 
ABDOMEN:                                                                     CNS: 
INVESTIGATION 
1. random blood sugar : 
2. Serum Na+, K+           :       
3. Serum amylase          : 
4. serum bilirubin          : 
5. serum calcium           : 
6. serum magnesium     : 
7. serum albumin           : 
8. EEG                              : 
9. CT- brain                     : 
 
 
 
SIGNATURE OF INVESTIGATOR                                             SIGNATURE OF GUIDE 
PATIENT CONSENT FORM 
 
STUDY DETAIL : 
STUDY CENTRE : 
PATIENT’S NAME  : 
PATIENT’S AGE : 
IDENTIFICATION NUMBER : 
 
                    I confirm that I have understood the purpose and procedure of the above study. I have 
the opportunity to ask questions and all my questions and doubts have been answered to my 
complete satisfaction. 
                    I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being affected. 
                    I understand that the sponsor of the clinical study, others working on the sponsor’s 
behalf, the ethical committee and the regulatory authorities will not need my permission to look at 
my health records, both in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree to this access. However I 
understand that my identity would not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use of any data or results that 
arise from this study. 
                    I hereby consent to participate in this study. 
        I hereby give permission to undergo complete clinical examination and diagnostic tests including 
haematological, biochemical, radiological tests. 
 
 
 
                                                                                                                               Signature/thumb impression: 
 
  
 
 
  
 
 
 
 
Name 
Ag
e 
S
e
x I.P.No 
C
a
g
e RBS 
S.Na
+ S.K+ 
S.A
myl
ase 
S.Bil
irubi
n 
S.Al
bum
in 
S.Ca
2+ 
S.M
g2+ 
Corr
ecte
d 
Ca2
+ 
imran 35 M 7290 1 92 137 4.6 44 0.9 4.2 8.7 1.7 na 
elavarasu 42 M 7565 1 101 136 3.7 80 0.4 4.3 8.9 2 na 
gandhi 52 M 7592 1 92 142 4.2 44 1 4.3 8.5 2.2 na 
angu 39 M 8898 1 101 142 3.5 64 0.4 4.4 8.6 1.4 na 
kannan 50 M 9016 1 80 142 4.7 32 0.6 4.2 9.2 1.9 na 
ravi 43 M 9030 1 112 138 3.8 80 0.7 4.4 9.3 1.6 na 
kanniah 43 M 9241 1 108 140 3.7 39 0.9 4.6 10.3 1.8 na 
nagarajan 39 M 9319 1 116 143 4.6 26 0.4 3.9 9.9 2.1 10 
venkatesan 30 M 9446 1 92 137 3.7 27 0.9 4.3 8.7 1.7 na 
thangaraj 45 M 9941 1 107 144 3.5 54 0.5 4.3 8.5 2 na 
saravanan 37 M 10098 1 116 142 3.7 72 0.8 4.6 8.6 2.1 na 
rajendran 46 M 10564 1 108 140 4.2 36 0.3 4 10.1 1.3 na 
mahesh 37 M 11920 1 114 144 3.7 66 0.7 4.6 9.4 2.1 na 
bazeer 46 M 12345 1 92 136 3.5 54 0.8 4.6 8.6 1.7 na 
gopalan 30 M 12495 1 113 142 3.7 58 0.9 3.4 10.1 2 10.6 
munusamy 48 M 12721 1 122 142 4.2 44 0.4 4.2 8.9 1.5 na 
ameer 52 M 12814 1 82 136 3.7 72 1.1 4.2 9.3 2.1 na 
ramanan 39 M 12848 1 124 144 3.8 49 1 4.4 8.7 2 na 
anbarasu 49 M 13566 1 102 136 4.2 47 0.6 3.6 10 2.1 10.2 
chinnatha
mbi 30 M 13696 1 136 139 4.4 58 0.6 4.2 8.6 1.3 na 
karthikeya
n 44 M 14097 1 105 137 5 24 0.6 4.6 8.7 1.87 na 
gopal 29 M 14235 1 82 142 3.6 53 0.4 4.5 9.6 2 na 
kesavan 37 M 14369 1 116 `137 4.2 36 0.9 4.6 9.9 1.6 na 
gopi 43 M 14401 1 124 142 3.7 24 0.8 3.8 9.4 1.7 9.6 
ravi 49 M 14476 1 102 143 3.7 46 0.5 4.2 10.3 1.9 na 
munusamy 46 M 15129 1 102 141 3.9 36 0.8 4.6 9.5 2 na 
venganna 35 M 15231 1 124 139 4.2 55 0.8 4.6 9.6 2.1 na 
raju 52 M 15409 1 109 144 3.6 44 0.6 4.7 8.7 1.7 na 
suban 38 M 15584 1 92 138 3.7 58 0.8 4 8.6 1.8 na 
satheesh 43 M 15582 1 92 137 4.4 34 0.7 4.5 9.4 1.7 na 
anil 43 M 16157 1 112 142 3.6 43 0.7 4.7 8.6 1.8 na 
thirunavuk
arasu 45 M 16707 1 118 145 4.7 62 0.9 4.2 9.7 1.9 na 
ramesh 52 M 16740 1 142 136 4.2 32 0.3 4.4 9.5 1.4 na 
selvamani 46 M 16763 1 106 142 3.7 69 0.9 4.6 9.7 1.9 na 
ganapathy 37 M 17021 1 122 139 4.1 82 0.9 4.7 8.7 1.3 na 
angu 53 M 17024 1 101 143 3.6 90 0.5 4.8 8.5 1.2 na 
ganesh 45 M 17269 1 150 143 3.5 26 0.7 4.3 8.6 2.2 na 
vasudevan 46 M 17405 1 132 136 4.2 78 0.9 4.3 9.6 2.2 na 
suresh 
kumar 38 M 17905 1 106 136 4.3 64 0.8 4.7 9.7 2 na 
martin 47 M 18138 1 135 138 4.4 46 0.7 4 9.5 1.8 na 
kannabiran 39 M 18422 1 91 142 3.6 44 0.7 4.6 9.8 1.4 na 
ganesan 45 M 18731 1 126 142 3.5 72 0.7 4.8 8.6 1.9 na 
kannan 39 M 19054 1 142 140 3.8 24 0.7 4.7 8.5 1.4 na 
sampath 51 M 19135 1 126 139 4.4 50 0.8 4 8.7 1.8 na 
sivakumar 39 M 19539 1 101 142 3.6 44 0.4 4 9.7 1.5 na 
dhayalan 36 M 19776 1 92 140 4 46 0.5 4.2 9.4 2 na 
velusamy 42 M 20222 1 136 136 4.1 34 1.1 4.2 8.4 1.4 na 
ramakrishn
an 41 M 20588 1 102 136 4.4 80 0.5 4.4 8.6 2.1 na 
srinivasan 46 
M
` 21378 1 110 142 3.6 52 0.5 4.6 8.6 1.3 na 
john 44 M 21646 1 132 135 4 46 0.9 4.2 9.5 1.9 na 
nazeer 35 M 21652 1 92 136 4.1 34 0.8 4.2 9.4 1.6 na 
srinivasan 47 M 21685 1 132 142 4.3 54 0.9 4.4 9.5 2.1 na 
mani 52 M 21717 1 82 135 4.4 80 0.3 4 9.2 1.5 na 
jayakumar 43 M 21847 1 102 137 3.6 45 0.7 4.1 9.6 2 na 
elumalai 50 M 21919 1 152 139 4.2 53 0.5 4.3 9.8 1.9 na 
venkatesan 49 M 21254 1 131 141 3.8 52 1.1 4.6 9.2 1.8 na 
 
 
 
 
 
 
 
 
 
Name Age 
S
e
x I.P.No 
C
a
g
e RBS 
S.Na
+ S.K+ 
S.A
myl
ase 
S.Bil
irubi
n 
S.Al
bum
in 
S.Ca
2+ 
S.M
g2+ 
Corr
ecte
d 
Ca2
+ 
kaboor 36 M 8672 0 102 136 3.6 42 0.5 4.2 9.2 1.9 NA 
murugan 30 m 8764 0 132 142 4 42 0.6 4.3 8.9 2.1 NA 
veerappan 38 m 8766 0 152 140 4.3 26 1.1 4.3 9.3 1.8 NA 
muralidhar
an 42 m 8711 0 102 136 4.1 47 0.3 4 9.9 1.7 NA 
ramanatha
n 34 m 9120 0 92 144 3.6 52 0.9 4.2 9 1.4 NA 
ganesan 44 m 9133 0 82 139 4.5 32 0.7 4.6 9.2 1.8 NA 
thirunavuk
arasu 45 m 9295 0 142 136 4.3 52 0.7 4.3 9.3 2.1 NA 
chakkarapa
ni 36 m 9548 0 104 136 3.7 42 0.6 4.3 8.5 1.4 NA 
krishnan 46 m 10031 0 102 138 3.9 49 0.9 4.7 9.6 4.7 NA 
muthulinga
m 39 m 10089 0 106 138 4.2 36 0.8 4.3 9.2 1.7 NA 
nandakum
ar 47 m 10157 0 139 137 4.5 54 0.6 4.3 8.6 1.9 NA 
balaji 48 m 10212 0 90 137 4.1 35 1 4 9.9 2.2 NA 
selvakumar 40 m 10414 0 142 145 3.6 72 0.3 4.1 8.4 2.3 NA 
dhanakotti 49 m 10661 0 109 142 3.5 37 0.7 4 8.6 1.8 NA 
kumar 38 m 10662 0 82 135 4.3 39 0.6 4.2 9.2 2.2 NA 
manohara
n 50 m 10707 0 108 137 4.3 44 0.8 4.2 9.1 1.6 NA 
jayapal 17 m 10791 0 116 137 4 38 0.5 4.3 8.9 1.4 NA 
loganathan 38 m 11125 0 123 143 3.5 45 0.9 4.6 8.9 1.5 NA 
sikkander 42 m 11153 0 126 135 4.1 53 0.5 4.6 9.4 2 NA 
shankar 48 m 11317 0 90 139 4.9 26 0.3 4.1 9.4 2 NA 
bhagavan 37 m 11570 0 82 137 4.3 37 0.9 4.3 9.1 1.7 NA 
mohan 55 m 11584 0 101 139 4.5 39 0.5 4.4 9.5 2.1 NA 
arunachala
m 43 m 11658 0 130 136 3.6 42 0.5 4 9.8 1.5 NA 
sarath 
kumar 37 m 12854 0 80 138 4.2 39 0.7 4 8.8 1.6 NA 
subramani 29 m 12732 0 142 131 3.9 46 0.9 4.4 9 1.5 NA 
subramani 46 m 12932 0 100 136 4.2 52 1 4 8.6 1.9 NA 
umapathy 33 m 14531 0 124 138 3.7 39 0.4 4.4 9.1 1.7 NA 
kabali 48 m 14694 0 96 142 4.3 38 0.4 4.2 9 1.8 NA 
daniel 
moses 32 m 14696 0 127 139 4.4 52 0.8 4.3 8.9 1.9 NA 
krishnasam
y 49 m 14817 0 111 136 4.1 42 0.5 4 8.7 1.8 NA 
premkuma
r 51 m 14859 0 107 136 4 38 0.7 4.1 9.2 2.1 NA 
ponnan 45 m 14900 0 138 135 4.2 45 0.5 4.1 9.2 1.6 NA 
suryamoor
thy 30 m 15214 0 101 139 4.3 33 0.9 3.8 8.8 2.1 8.96 
devendran 39 m 17168 0 117 136 4.1 51 0.7 4.7 8.7 1.5 NA 
saravanan 46 m 17241 0 82 136 3.7 41 0.7 4..2 9.1 1.8 NA 
mohan 31 m 17709 0 112 137 3.8 52 0.6 3.9 8.9 1.5 9 
buviraj 48 m 17799 0 132 139 4.1 49 0.7 4.3 8.3 1.3 NA 
razool 
moiden 40 m 17960 0 108 144 3.8 28 0.8 4.4 10.3 1.7 NA 
abdul 1 42 m 18014 0 102 138 4.3 59 0.5 4.2 8.9 1.6 NA 
rosekumar 47 m 18159 0 83 138 4 38 0.7 4.3 9.3 1.9 NA 
naresh 32 m 18218 0 127 139 4.1 46 0.4 4 9 1.6 NA 
velu 36 m 18779 0 124 138 3.7 32 0.6 4.2 8.9 1.5 NA 
muralidhar
an 35 m 18886 0 91 144 3.6 42 0.7 4.4 9.1 1.6 NA 
ashok 48 m 19774 0 127 141 4.6 56 0.8 4.3 9 2 NA 
govindaraj 37 m 20013 0 117 137 3.5 40 0.6 4 10.2 1.6 NA 
angu 40 m 20104 0 104 138 3.9 29 0.5 4.3 8.6 1.5 NA 
suresh 
kumar 41 m 20227 0 108 139 4.3 42 0.9 4.4 8.7 1.9 NA 
kannan 50 m 20921 0 109 144 4.5 48 0.3 4 9.2 1.6 NA 
kuppuraj 39 m 21884 0 94 135 4 39 0.7 4.3 8.9 2 NA 
narayanan 22 m 22070 0 82 136 4 39 0.7 4.3 8.9 1.6 NA 
murugan 35 m 22248 0 122 135 4.1 32 0.9 3.9 8.8 1.4 NA 
anand 52 m 22322 0 101 136 4.7 31 0 4 8.8 1.5 NA 
deepan 34 m 22397 0 127 139 4.1 44 0.6 4.2 9.1 1.6 NA 
murugesan 55 m 22615 0 108 138 3.9 41 0.7 4.1 8.6 1.6 NA 
 
